<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="43011" whole_study_id="6896" phs="000282" v="22" p="13" createDate="2021-07-08T10:48:20-05:00" completedByGPADate="2021-08-13T22:11:51-05:00" modDate="2022-05-31T16:33:03-05:00" maxParentChildStudyModDate="2022-06-05T22:05:29-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v22.p13" parentAccession="phs000007.v33.p13" parentId="42995" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="NHEARD@BU.EDU" aid="2" auth="eRA" login="NHEARD@BU.EDU" fname="Nancy" lname="Heard-Costa" email="nheard@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="1000547429" aid="1" auth="cit" login="hongy5" fname="Yuling" mname="" lname="Hong" email="yuling.hong@nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2000641610" aid="1" auth="cit" login="virtav" fname="Valerie" mname="Christine" lname="Virta" email="valerie.virta@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions. Only full or expedited approvals are acceptable, and an ANNUAL IRB review is required base on the informed consents from the submitting institution. It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=47411&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2022 5 25.pdf" md5="b8d1073dfe8a21412dd79374decc876f" size="541979" modDate="2022-05-31T09:09:40-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="14" name="completed_by_gpa" title="Completed by GPA"/></Study><Study uid="38422" whole_study_id="6896" phs="000282" v="21" p="13" createDate="2020-05-11T09:38:37-05:00" completedByGPADate="2020-12-03T14:46:58-05:00" modDate="2021-07-08T10:48:23-05:00" maxParentChildStudyModDate="2022-01-25T16:16:22-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v21.p13" parentAccession="phs000007.v32.p13" parentId="38406" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=39878&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2020 10 30.pdf" md5="e4a10877cc14a5637b64e36769f682e6" size="542581" modDate="2020-11-06T10:37:47-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="32600" whole_study_id="6896" phs="000282" v="20" p="12" createDate="2018-12-12T08:21:38-05:00" completedByGPADate="2018-12-12T10:21:01-05:00" modDate="2020-09-01T10:11:23-05:00" maxParentChildStudyModDate="2020-09-01T11:12:57-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v20.p12" parentAccession="phs000007.v31.p12" parentId="32587" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2000452640" aid="1" auth="cit" login="chensh2" fname="Shu Hui" mname="" lname="Chen" email="shuhui.chen@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=36892&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2019 10 30.pdf" md5="f9eb3c1c804b68add0eb23fdd5ea9c26" size="474094" modDate="2019-11-18T14:06:19-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="23952" whole_study_id="6896" phs="000282" v="19" p="11" createDate="2017-03-15T22:53:35-05:00" completedByGPADate="2017-06-13T16:12:36-05:00" modDate="2020-09-01T09:18:30-05:00" maxParentChildStudyModDate="2020-09-01T11:26:54-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v19.p11" parentAccession="phs000007.v30.p11" parentId="23940" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2000452640" aid="1" auth="cit" login="chensh2" fname="Shu Hui" mname="" lname="Chen" email="shuhui.chen@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=28542&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2018 03 14.pdf" md5="2cab8305bec76413eda509d08ee9d2b4" size="319813" modDate="2018-03-14T16:08:20-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="20273" whole_study_id="6896" phs="000282" v="18" p="10" createDate="2016-06-22T16:10:39-05:00" completedByGPADate="2016-06-27T14:19:05-05:00" modDate="2017-01-26T10:47:09-05:00" maxParentChildStudyModDate="2020-09-01T11:15:28-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v18.p10" parentAccession="phs000007.v29.p10" parentId="20261" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011574474" aid="1" auth="cit" login="runkoa" fname="Alexander" mname="Peter" lname="Runko" email="alexander.runko@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC><File uri="dbgapssws.cgi?blob_id=19137&amp;file=get&amp;page=file" filename="Framingham Cohort DUC 2016-04-25.rtf" md5="6b1cef05c59ce33492c0d0a15698bd04" size="202542" modDate="2016-04-25T10:53:08-05:00" content-type="application/msword"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=20279&amp;file=get&amp;page=file" filename="Framingham Cohort DUC 2016-04-25.rtf.pdf" md5="a463a0ca787485a4bdd73f4afed28f6c" size="170310" modDate="2016-06-23T00:10:43-05:00" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=21692&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2016 09 30.pdf" md5="aec828935fec56d3ffef3c77c25e82cf" size="240976" modDate="2016-10-05T17:56:41-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="18888" whole_study_id="6896" phs="000282" v="17" p="10" createDate="2016-04-06T13:08:17-05:00" completedByGPADate="2016-04-25T10:59:19-05:00" modDate="2016-06-10T01:11:15-05:00" maxParentChildStudyModDate="2020-09-01T11:34:42-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v17.p10" parentAccession="phs000007.v28.p10" parentId="18876" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011574474" aid="1" auth="cit" login="runkoa" fname="Alexander" mname="Peter" lname="Runko" email="alexander.runko@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC><File uri="dbgapssws.cgi?blob_id=19137&amp;file=get&amp;page=file" filename="Framingham Cohort DUC 2016-04-25.rtf" md5="6b1cef05c59ce33492c0d0a15698bd04" size="202542" modDate="2016-04-25T10:53:08-05:00" content-type="application/msword"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=19139&amp;file=get&amp;page=file" filename="Framingham Cohort DUC 2016-04-25.rtf.pdf" md5="35d67c3060f5a60e68d9b033638b6bb5" size="170278" modDate="2016-04-25T10:55:19-05:00" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=19136&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2016 04 01.pdf" md5="02d4873855e5b1ad6f59e48d6da8dd5b" size="235277" modDate="2016-04-25T10:44:38-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="16452" whole_study_id="6896" phs="000282" v="16" p="10" createDate="2015-08-24T09:51:59-05:00" completedByGPADate="2015-10-26T10:27:30-05:00" modDate="2016-01-15T11:25:21-05:00" maxParentChildStudyModDate="2020-09-01T09:27:11-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v16.p10" parentAccession="phs000007.v27.p10" parentId="16442" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC><File uri="dbgapssws.cgi?blob_id=18294&amp;file=get&amp;page=file" filename="Framingham Cohort DUC 2016-01-27.rtf" md5="73dddbc6fa07b1036e0d783deeb35391" size="204847" modDate="2016-01-27T09:31:15-05:00" content-type="application/msword"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=18296&amp;file=get&amp;page=file" filename="Framingham Cohort DUC 2016-01-27.rtf.pdf" md5="efb494a31702754000f5efd08d0ff49f" size="169929" modDate="2016-01-27T10:10:24-05:00" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=18292&amp;file=get&amp;page=file" filename="2015 10 07 1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2015 10 07.pdf" md5="9f2a24a293e0ae4accf21eb8c4c329aa" size="230416" modDate="2016-01-27T09:17:39-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="13277" whole_study_id="6896" phs="000282" v="15" p="10" createDate="2015-02-25T11:19:43-05:00" completedByGPADate="2015-03-19T10:34:30-05:00" modDate="2020-09-01T11:27:38-05:00" maxParentChildStudyModDate="2020-09-01T11:27:38-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v15.p10" parentAccession="phs000007.v26.p10" parentId="13267" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC><File uri="dbgapssws.cgi?blob_id=12053&amp;file=get&amp;page=file" filename="20140811 DUC Framingham.pdf" md5="b3408845c9578e67c4cd3068fc541119" size="131423" modDate="2014-08-15T08:53:51-05:00" content-type="application/pdf"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=12053&amp;file=get&amp;page=file" filename="20140811 DUC Framingham.pdf" md5="b3408845c9578e67c4cd3068fc541119" size="131423" modDate="2014-08-15T08:53:51-05:00" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=15758&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2015 04 28.pdf" md5="50615bd7ff19fc1c61833ea6e0a2b987" size="235479" modDate="2015-06-23T14:11:44-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="910" CGType="cg_class_other" title="Exchange Area" name="EA-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  Pre-release exchange area for use by study investigators only.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="12429" whole_study_id="6896" phs="000282" v="14" p="9" createDate="2014-10-08T15:06:30-05:00" completedByGPADate="2014-10-20T15:11:52-05:00" modDate="2014-12-24T01:05:51-05:00" maxParentChildStudyModDate="2020-09-01T11:14:13-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v14.p9" parentAccession="phs000007.v25.p9" parentId="12419" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC><File uri="dbgapssws.cgi?blob_id=12053&amp;file=get&amp;page=file" filename="20140811 DUC Framingham.pdf" md5="b3408845c9578e67c4cd3068fc541119" size="131423" modDate="2014-08-15T08:53:51-05:00" content-type="application/pdf"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=12053&amp;file=get&amp;page=file" filename="20140811 DUC Framingham.pdf" md5="b3408845c9578e67c4cd3068fc541119" size="131423" modDate="2014-08-15T08:53:51-05:00" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=12464&amp;file=get&amp;page=file" filename="2014 10 17_1 Non-contract and Contract Phenotypic Dataset Acknowledgement.pdf" md5="40c169d82d9c2c142001a23f6eec06af" size="219125" modDate="2014-10-23T16:05:10-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="910" CGType="cg_class_other" title="Exchange Area" name="EA-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  Pre-release exchange area for use by study investigators only.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="11280" whole_study_id="6896" phs="000282" v="13" p="9" createDate="2014-04-28T12:26:18-05:00" completedByGPADate="2014-05-06T10:36:37-05:00" modDate="2020-09-01T09:11:09-05:00" maxParentChildStudyModDate="2020-09-01T11:37:32-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v13.p9" parentAccession="phs000007.v24.p9" parentId="11271" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC><File uri="dbgapssws.cgi?blob_id=12053&amp;file=get&amp;page=file" filename="20140811 DUC Framingham.pdf" md5="b3408845c9578e67c4cd3068fc541119" size="131423" modDate="2014-08-15T08:53:51-05:00" content-type="application/pdf"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=12053&amp;file=get&amp;page=file" filename="20140811 DUC Framingham.pdf" md5="b3408845c9578e67c4cd3068fc541119" size="131423" modDate="2014-08-15T08:53:51-05:00" content-type="application/pdf"/></DUC_PDF><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=12028&amp;file=get&amp;page=file" filename="2014 8 11_1 Non-contract and Contract Phenotypic Dataset Acknowledgement.pdf" md5="c8f86e5fcd28a53f824c28cd4f00632a" size="190418" modDate="2014-08-12T12:04:08-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="910" CGType="cg_class_other" title="Exchange Area" name="EA-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  Pre-release exchange area for use by study investigators only.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="10874" whole_study_id="6896" phs="000282" v="12" p="8" createDate="2014-01-30T13:18:04-05:00" completedByGPADate="2014-03-19T13:31:50-05:00" modDate="2020-09-01T09:09:27-05:00" maxParentChildStudyModDate="2020-09-01T11:24:07-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v12.p8" parentAccession="phs000007.v23.p8" parentId="10865" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC><File uri="dbgapssws.cgi?blob_id=10975&amp;file=get&amp;page=file" filename="DUC_FraminghamCohort_v2 2013.12.24 (1).docx" md5="e3124a5597e47f1ce9dbed45f0f58f9b" size="132746" modDate="2014-03-04T14:47:06-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=10974&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2014 2 14.pdf" md5="af99b2f44c80316273f9e6c84239febe" size="193003" modDate="2014-03-04T14:37:18-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="910" CGType="cg_class_other" title="Exchange Area" name="EA-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  Pre-release exchange area for use by study investigators only.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="10210" whole_study_id="6896" phs="000282" v="11" p="8" createDate="2013-11-21T18:06:56-05:00" modDate="2020-09-01T10:27:21-05:00" maxParentChildStudyModDate="2020-09-01T11:16:43-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v11.p8" parentAccession="phs000007.v22.p8" parentId="10200" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC><File uri="dbgapssws.cgi?blob_id=10362&amp;file=get&amp;page=file" filename="DUC_FraminghamCohort_v2 2013.12.24.docx" md5="7e19634092928f6d721b4707e49a6ee7" size="132863" modDate="2013-12-24T13:01:58-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=10361&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2013 11 21.pdf" md5="6c843b4fad2851fe65a8795f68b22746" size="172349" modDate="2013-12-24T11:13:03-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="910" CGType="cg_class_other" title="Exchange Area" name="EA-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  Pre-release exchange area for use by study investigators only.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="9755" whole_study_id="6896" phs="000282" v="10" p="8" createDate="2013-07-09T17:02:49-05:00" modDate="2013-10-24T13:15:05-05:00" maxParentChildStudyModDate="2020-09-01T11:12:29-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v10.p8" parentAccession="phs000007.v21.p8" parentId="9747" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term>DATA USE LIMITATION FOR FHS:
Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).
Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number. Data use is limited by consent groups to the following two groups: a) Health/Medical/Biomedical and related Methods and b) Health/Medical/Biomedical and related Methods for Non-Profit Use Only.
</ic_specific_access_term><DUC><File uri="dbgapssws.cgi?blob_id=9012&amp;file=get&amp;page=file" filename="Framingham DUC_12-18-12.docx" md5="8e4002fba4b0f06cf1486162925dabcc" size="85383" modDate="2013-01-15T07:55:05-05:00" content-type="application/octet-stream"/></DUC><DUC_SupplementaryDocuments><File uri="dbgapssws.cgi?blob_id=9642&amp;file=get&amp;page=file" filename="Non-contract and Contract Phenotypic Dataset Acknowledgement 2013 6 13.doc" md5="55e8f42081835cea3cbfcb5f6d3804b8" size="223744" modDate="2013-06-18T11:58:42-05:00" content-type="application/msword"/></DUC_SupplementaryDocuments><DUC_AcknowledgementStatement><File uri="dbgapssws.cgi?blob_id=9930&amp;file=get&amp;page=file" filename="1 Non-contract and Contract Phenotypic Dataset Acknowledgement 2013 8 2.pdf" md5="7c0a9566541bca2d9e0e0b2140d6b530" size="169017" modDate="2013-08-14T15:34:50-05:00" content-type="application/pdf"/></DUC_AcknowledgementStatement><ConsentGroup uid="731" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, MDS)" name="HMB-IRB-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU, MDS)" name="HMB-IRB-NPU-MDS" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

Use of the Framingham data deposited in dbGaP is restricted to research on: genotypephenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations. All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC). Additionally, the Framingham data may not be used 
to: 
o Investigate individual pedigree structures or individual participant genotypes for the 
purpose of identifying individuals or families; or explore issues such as non-maternity or 
non-paternity.
o Investigate topics that could be considered as stigmatizing an individual or group.
o Assess outcomes that are not related to health or disease conditions (note: methodological 
research that will serve as a prelude to health or disease research is permitted).
Please note that only full or expedited approvals will be accepted.</Use-Restriction></ConsentGroup><ConsentGroup uid="910" CGType="cg_class_other" title="Exchange Area" name="EA-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  Pre-release exchange area for use by study investigators only.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="9250" whole_study_id="6896" phs="000282" v="9" p="8" createDate="2013-03-29T08:22:25-05:00" modDate="2013-07-03T13:47:36-05:00" maxParentChildStudyModDate="2020-09-01T11:32:03-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v9.p8" parentAccession="phs000007.v20.p8" parentId="9242" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term/><DUC><File uri="dbgapssws.cgi?blob_id=9012&amp;file=get&amp;page=file" filename="Framingham DUC_12-18-12.docx" md5="8e4002fba4b0f06cf1486162925dabcc" size="85383" modDate="2013-01-15T07:55:05-05:00" content-type="application/octet-stream"/></DUC><DUC_SupplementaryDocuments><File uri="dbgapssws.cgi?blob_id=9642&amp;file=get&amp;page=file" filename="Non-contract and Contract Phenotypic Dataset Acknowledgement 2013 6 13.doc" md5="55e8f42081835cea3cbfcb5f6d3804b8" size="223744" modDate="2013-06-18T11:58:42-05:00" content-type="application/msword"/></DUC_SupplementaryDocuments><ConsentGroup uid="731" CGType="cg_class_other" title="Health/Medical/Biomedical with Methods with IRB" name="HMB-MDS-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  

</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_other" title="Health/Medical/Biomedical with Non-Profit Use Only with Methods with IRB" name="HMB-NPU-MDS-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research by investigators employed by non-profit organizations only.
</Use-Restriction></ConsentGroup><ConsentGroup uid="910" CGType="cg_class_other" title="Exchange Area" name="EA-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  Pre-release exchange area for use by study investigators only.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="8855" whole_study_id="6896" phs="000282" v="8" p="7" createDate="2012-11-13T14:08:50-05:00" modDate="2013-03-29T00:00:24-05:00" maxParentChildStudyModDate="2020-09-01T09:20:33-05:00" handle="CARe" num_participants="14000"><StudyInfo accession="phs000282.v8.p7" parentAccession="phs000007.v19.p7" parentId="8850" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010404851" aid="1" auth="cit" login="gjp" fname="George" mname="John" lname="Papanicolaou" email="gjp@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term/><DUC><File uri="dbgapssws.cgi?blob_id=9012&amp;file=get&amp;page=file" filename="Framingham DUC_12-18-12.docx" md5="8e4002fba4b0f06cf1486162925dabcc" size="85383" modDate="2013-01-15T07:55:05-05:00" content-type="application/octet-stream"/></DUC><DUC_SupplementaryDocuments><File uri="dbgapssws.cgi?blob_id=8581&amp;file=get&amp;page=file" filename="Non-contract and Contract Phenotypic Dataset Acknowledgement 2012 09 10.doc" md5="d417d5cecfdf55b55041c492162c375e" size="216576" modDate="2012-09-11T10:33:31-05:00" content-type="application/msword"/></DUC_SupplementaryDocuments><ConsentGroup uid="731" CGType="cg_class_other" title="Health/Medical/Biomedical with Methods with IRB" name="HMB-MDS-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  

</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_other" title="Health/Medical/Biomedical with Non-Profit Use Only with Methods with IRB" name="HMB-NPU-MDS-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research by investigators employed by non-profit organizations only.
</Use-Restriction></ConsentGroup><ConsentGroup uid="910" CGType="cg_class_other" title="Exchange Area" name="EA-IRB" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>Use of the Framingham data deposited in dbGaP is restricted to research on: genotype-phenotype associations; molecular phenotype (e.g., gene expression; microRNA)-phenotype associations; and proteomics/metabolomics-phenotype associations.  All other phenotype-only analyses are prohibited (note: investigators may request data for such phenotype-only analyses through NHLBI&#8217;s BioLINCC).  Additionally, the Framingham data may not be used to: 
o     Investigate individual pedigree structures or individual participant genotypes for the purpose of identifying individuals or families; or explore issues such as non-maternity or non-paternity.
o     Investigate topics that could be considered as stigmatizing an individual or group.
o     Assess outcomes that are not related to health or disease conditions (note: methodological research that will serve as a prelude to health or disease research is permitted).

Data users are responsible for ensuring that all uses of the data are consistent with federal, state, and local laws and any relevant institutional policies, and that the data are always maintained in a secured fashion. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). It is anticipated that, at least in some cases, the FHS data will be updated with additional information and will be so identified by an appropriate version number.

This FHS consent group allows for use of the data in health/medical/biomedical research.  Pre-release exchange area for use by study investigators only.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="8086" whole_study_id="6896" phs="000282" v="7" p="7" createDate="2012-05-09T18:11:36-05:00" modDate="2012-10-23T13:52:54-05:00" maxParentChildStudyModDate="2020-09-01T11:21:19-05:00" num_participants="14000"><StudyInfo accession="phs000282.v7.p7" parentAccession="phs000007.v18.p7" parentId="8081" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACUPPLES" aid="2" auth="eRA" login="ACUPPLES" fname="L." mname="ADRIENNE" lname="Cupples" email="adrienne@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0010043312" aid="1" auth="cit" login="sholinsp" fname="Phyliss" mname="Dawn" lname="Sholinsky" email="sholinsp@nhlbi.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0012597367" aid="1" auth="cit" login="krullh" fname="Holly" mname="K" lname="Krull" email="krullh@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement/><ic_specific_access_term/><DUC><File uri="dbgapssws.cgi?blob_id=7787&amp;file=get&amp;page=file" filename="Framingham DUC_03-06-12.docx" md5="c60b79dccaf32ceccc9030b0045a0854" size="80808" modDate="2012-03-21T13:22:04-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC><DUC_SupplementaryDocuments><File uri="dbgapssws.cgi?blob_id=8581&amp;file=get&amp;page=file" filename="Non-contract and Contract Phenotypic Dataset Acknowledgement 2012 09 10.doc" md5="d417d5cecfdf55b55041c492162c375e" size="216576" modDate="2012-09-11T10:33:31-05:00" content-type="application/msword"/></DUC_SupplementaryDocuments><ConsentGroup uid="731" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by the Framingham Heart Study Participants allows use of these data by investigators employed by non-profit and for-profit organizations. These data may be used by private companies in the development of diagnostics and therapeutics under the current consent.
</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_other" title="Non Profit Use Only" name="NPU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by Framingham Heart Study participants allows use of these genetic data by investigators employed by non-profit organizations only. Direct use of these data by private companies to develop diagnostics or therapeutics is NOT allowed under the current consent.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="7723" whole_study_id="6896" phs="000282" v="6" p="6" createDate="2012-02-28T13:49:35-05:00" modDate="2012-02-28T13:49:35-05:00" maxParentChildStudyModDate="2012-03-21T13:22:00-05:00" num_participants="14000"><StudyInfo accession="phs000282.v6.p6" parentAccession="phs000007.v17.p6" parentId="7718" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes><Funding>R01 DK072041-01</Funding></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="DALTSHULER" aid="2" auth="eRA" login="DALTSHULER" fname="David" lname="Altshuler" email="altshuler@molbio.mgh.harvard.edu"><Role>PI</Role><Organization>BROAD INSTITUTE, INC.MASSACHUSETTS GENERAL HOSPITAL</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011073112" aid="1" auth="cit" login="paltood" fname="Dina" mname="N" lname="Paltoo" email="dp249p@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><DUC><File uri="dbgapssws.cgi?blob_id=7787&amp;file=get&amp;page=file" filename="Framingham DUC_03-06-12.docx" md5="c60b79dccaf32ceccc9030b0045a0854" size="80808" modDate="2012-03-21T13:22:04-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC><DUC_SupplementaryDocuments><File uri="dbgapssws.cgi?blob_id=7788&amp;file=get&amp;page=file" filename="FHS Non-contract and Contract Phenotypic Dataset Acknowledgement 03192012.docx" md5="2f00f8217ee6cef4eb29880bfe461fda" size="38255" modDate="2012-03-21T13:22:23-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC_SupplementaryDocuments><ConsentGroup uid="731" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by the Framingham Heart Study Participants allows use of these data by investigators employed by non-profit and for-profit organizations. These data may be used by private companies in the development of diagnostics and therapeutics under the current consent.
</Use-Restriction></ConsentGroup><ConsentGroup uid="732" CGType="cg_class_other" title="Non Profit Use Only" name="NPU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by Framingham Heart Study participants allows use of these genetic data by investigators employed by non-profit organizations only. Direct use of these data by private companies to develop diagnostics or therapeutics is NOT allowed under the current consent.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="7508" whole_study_id="6896" phs="000282" v="5" p="6" createDate="2011-11-01T14:06:47-05:00" modDate="2011-11-22T15:42:52-05:00" maxParentChildStudyModDate="2011-12-15T17:37:44-05:00" num_participants="14000"><StudyInfo accession="phs000282.v5.p6" parentAccession="phs000007.v16.p6" parentId="7505" parent_whole_study_id="5361"><BioProject id="PRJNA77831" entrez_id="77831" type="bp_data_submission"/><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes><Funding>R01 DK072041-01</Funding></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="DALTSHULER" aid="2" auth="eRA" login="DALTSHULER" fname="David" lname="Altshuler" email="altshuler@molbio.mgh.harvard.edu"><Role>PI</Role><Organization>BROAD INSTITUTE, INC.MASSACHUSETTS GENERAL HOSPITAL</Organization></Person><Person nedid="0010043312" aid="1" auth="cit" login="sholinsp" fname="Phyliss" mname="Dawn" lname="Sholinsky" email="sholinsp@nhlbi.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011073112" aid="1" auth="cit" login="paltood" fname="Dina" mname="N" lname="Paltoo" email="dp249p@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><DUC><File uri="dbgapssws.cgi?blob_id=7027&amp;file=get&amp;page=file" filename="Framingham New DUC 5-24-11.docx" md5="c197122f97d478d0575a613650d45fd9" size="79986" modDate="2011-05-25T12:34:31-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC><DUC_SupplementaryDocuments><File uri="dbgapssws.cgi?blob_id=7577&amp;file=get&amp;page=file" filename="Non-contract and Contract Phenotypic Dataset Acknowledgement 11292011.docx" md5="02c512754e27d76b033c8a69f9a3c020" size="38650" modDate="2011-12-08T15:35:01-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC_SupplementaryDocuments><ConsentGroup uid="653" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by the Framingham Heart Study Participants allows use of these data by investigators employed by non-profit and for-profit organizations. These data may be used by private companies in the development of diagnostics and therapeutics under the current consent.
</Use-Restriction></ConsentGroup><ConsentGroup uid="654" CGType="cg_class_other" title="Non Profit Use Only" name="NPU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by Framingham Heart Study participants allows use of these genetic data by investigators employed by non-profit organizations only. Direct use of these data by private companies to develop diagnostics or therapeutics is NOT allowed under the current consent.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="7208" whole_study_id="6896" phs="000282" v="4" p="6" createDate="2011-08-03T11:49:14-05:00" modDate="2011-08-03T11:49:14-05:00" maxParentChildStudyModDate="2011-10-19T16:37:59-05:00" num_participants="14000"><StudyInfo accession="phs000282.v4.p6" parentAccession="phs000007.v15.p6" parentId="7205" parent_whole_study_id="5361"><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011073112" aid="1" auth="cit" login="paltood" fname="Dina" mname="N" lname="Paltoo" email="dp249p@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><DUC><File uri="dbgapssws.cgi?blob_id=7027&amp;file=get&amp;page=file" filename="Framingham New DUC 5-24-11.docx" md5="c197122f97d478d0575a613650d45fd9" size="79986" modDate="2011-05-25T12:34:31-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC><DUC_SupplementaryDocuments><File uri="dbgapssws.cgi?blob_id=7308&amp;file=get&amp;page=file" filename="Non-contract and Contract Phenotypic Dataset Acknowledgement 07222011_V1.doc" md5="be977bf541884a292562bc21a16cad1a" size="159744" modDate="2011-08-25T12:54:19-05:00" content-type="application/msword"/></DUC_SupplementaryDocuments><ConsentGroup uid="537" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by the Framingham Heart Study Participants allows use of these data by investigators employed by non-profit and for-profit organizations. These data may be used by private companies in the development of diagnostics and therapeutics under the current consent.
</Use-Restriction></ConsentGroup><ConsentGroup uid="538" CGType="cg_class_other" title="Non Profit Use Only" name="NPU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by Framingham Heart Study participants allows use of these genetic data by investigators employed by non-profit organizations only. Direct use of these data by private companies to develop diagnostics or therapeutics is NOT allowed under the current consent.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="7012" whole_study_id="6896" phs="000282" v="3" p="6" createDate="2011-05-18T11:26:51-05:00" modDate="2020-09-01T10:11:13-05:00" maxParentChildStudyModDate="2020-09-01T10:40:22-05:00" num_participants="14000"><StudyInfo accession="phs000282.v3.p6" parentAccession="phs000007.v14.p6" parentId="7009" parent_whole_study_id="5361"><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011073112" aid="1" auth="cit" login="paltood" fname="Dina" mname="N" lname="Paltoo" email="dp249p@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><DUC><File uri="dbgapssws.cgi?blob_id=7027&amp;file=get&amp;page=file" filename="Framingham New DUC 5-24-11.docx" md5="c197122f97d478d0575a613650d45fd9" size="79986" modDate="2011-05-25T12:34:31-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC><DUC_SupplementaryDocuments><File uri="dbgapssws.cgi?blob_id=6514&amp;file=get&amp;page=file" filename="Non-contract and Contract Phenotypic Dataset Acknowledgement 11-24-2010.doc" md5="4a352edeb3e0e95f975522a7e20532aa" size="157184" modDate="2010-11-29T15:15:53-05:00" content-type="application/msword"/></DUC_SupplementaryDocuments><ConsentGroup uid="473" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by the Framingham Heart Study Participants allows use of these data by investigators employed by non-profit and for-profit organizations. These data may be used by private companies in the development of diagnostics and therapeutics under the current consent.
</Use-Restriction></ConsentGroup><ConsentGroup uid="474" CGType="cg_class_other" title="Non Profit Use Only" name="NPU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by Framingham Heart Study participants allows use of these genetic data by investigators employed by non-profit organizations only. Direct use of these data by private companies to develop diagnostics or therapeutics is NOT allowed under the current consent.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="6896" whole_study_id="6896" phs="000282" v="2" p="5" createDate="2011-04-05T15:05:06-05:00" modDate="2022-02-15T09:23:38-05:00" maxParentChildStudyModDate="2022-02-15T09:24:17-05:00" num_participants="14000"><StudyInfo accession="phs000282.v2.p5" parentAccession="phs000007.v13.p5" parentId="6597" parent_whole_study_id="5361"><StudyNameEntrez>NHLBI Framingham Candidate Gene Association Resource (CARe)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>genotype_data</StudyType></StudyTypes><Description>
&lt;p&gt;&lt;b&gt;&lt;font color="#FF0000"&gt;Note: This study contains 50k genotypes from ~2,100 candidate genes across a range of cardiovascular,    metabolic, and inflammatory syndromes, produced as part of NHLBI&amp;#39;s Candidate Gene Association Resource (CARe) project.     Phenotypes for the Framingham study participants are available by requesting access to the Framingham SHARe     &lt;a href="./study.cgi?study_id=phs000007"&gt;phs000007&lt;/a&gt;.&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;         &lt;p&gt;&lt;b&gt;Startup of Framingham Heart Study.&lt;/b&gt; Cardiovascular disease (CVD) is the leading cause of death and serious    illness in the United States. In 1948, the Framingham Heart Study (FHS) -- under the direction of the National Heart    Institute (now known as the National Heart, Lung, and Blood Institute, NHLBI) -- embarked on a novel and ambitious project    in health research. At the time, little was known about the general causes of heart disease and stroke, but the death rates    for CVD had been increasing steadily since the beginning of the century and had become an American epidemic.&lt;/p&gt;   &lt;p&gt;The objective of the FHS was to identify the common factors or characteristics that contribute to CVD by following its    development over a long period of time in a large group of participants who had not yet developed overt symptoms of CVD    or suffered a heart attack or stroke.&lt;/p&gt;    &lt;p&gt;&lt;b&gt;Important links to apply for individual-level data&lt;/b&gt;     &lt;ol&gt;         &lt;li&gt;&lt;a href="http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?view_pdf&amp;stacc=phs000282.v1.p1" target="_blank"&gt;Data Use Certification Requirements (DUC)&lt;/a&gt;&lt;/li&gt;      &lt;li&gt;&lt;a href="GetPdf.cgi?id=phd001183.1" target="_blank"&gt;Instructions to Request Authorized Access&lt;/a&gt;&lt;/li&gt;         &lt;li&gt;&lt;a href="http://view.ncbi.nlm.nih.gov/dbgap-controlled" target="_blank"&gt;Apply here for controlled access to individual level data&lt;/a&gt;&lt;/li&gt;         &lt;li&gt;&lt;a href="GetPdf.cgi?id=phd000317" target="_blank"&gt;Participant Protection Policy FAQ&lt;/a&gt;&lt;/li&gt;      &lt;li&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetPdf.cgi?document_name=FHSAcknowledgement.pdf" target="_blank"&gt;FHS Acknowledgement Statements&lt;/a&gt;&lt;/li&gt;     &lt;/ol&gt;     &lt;/p&gt;   &lt;p&gt;&lt;b&gt;Design of Framingham Heart Study.&lt;/b&gt; In 1948, the researchers recruited 5,209 men and women between the ages    of 30 and 62 from the town of Framingham, Massachusetts, and began the first round of extensive physical examinations    and lifestyle interviews that they would later analyze for common patterns related to CVD development. Since 1948,    the subjects have returned to the study every two years for an examination consisting of a detailed medical history,    physical examination, and laboratory tests, and in 1971, the study enrolled a second-generation cohort -- 5,124 of    the original participants&amp;#39; adult children and their spouses -- to participate in similar examinations. The second    examination of the Offspring cohort occurred eight years after the first examination, and subsequent examinations    have occurred approximately every four years thereafter. In April 2002 the Study entered a new phase: the enrollment    of a third generation of participants, the grandchildren of the original cohort. The first examination of the Third    Generation Study was completed in July 2005 and involved 4,095 participants. Thus, the FHS has evolved into a    prospective, community-based, three generation family study. The FHS is a joint project of the National Heart,    Lung and Blood Institute and Boston University.&lt;/p&gt;   &lt;p&gt;&lt;b&gt;Research Areas in the Framingham Heart Study.&lt;/b&gt; Over the years, careful monitoring of the FHS population    has led to the identification of the major CVD risk factors -- high blood pressure, high blood cholesterol, smoking,    obesity, diabetes, and physical inactivity -- as well as a great deal of valuable information on the effects of    related factors such as blood triglyceride and HDL cholesterol levels, age, gender, and psychosocial issues.    Risk factors have been identified for the major components of CVD, including coronary heart disease, stroke,    intermittent claudication, and heart failure. It is also clear from research in the FHS and other studies that    substantial subclinical vascular disease occurs in the blood vessels, heart and brain that precedes clinical CVD.    With recent advances in technology, the FHS has enhanced its research capabilities and capitalized on its inherent    resources by the conduct of high resolution imaging to detect and quantify subclinical vascular disease in the major    blood vessels, heart and brain. These studies have included ultrasound studies of the heart (echocardiography) and    carotid arteries, computed tomography studies of the heart and aorta, and magnetic resonance imaging studies of    the brain, heart, and aorta. Although the Framingham cohort is primarily white, the importance of the major CVD    risk factors identified in this group have been shown in other studies to apply almost universally among racial    and ethnic groups, even though the patterns of distribution may vary from group to group. In the past half century,    the Study has produced approximately 1,200 articles in leading medical journals. The concept of CVD risk factors    has become an integral part of the modern medical curriculum and has led to the development of effective treatment    and preventive strategies in clinical practice.&lt;/p&gt;   &lt;p&gt;In addition to research studies focused on risk factors, subclinical CVD and clinically apparent CVD, Framingham    investigators have also collaborated with leading researchers from around the country and throughout the world on    projects involving some of the major chronic illnesses in men and women, including dementia, osteoporosis and arthritis,    nutritional deficiencies, eye diseases, hearing disorders, and chronic obstructive lung diseases.&lt;/p&gt;   &lt;p&gt;&lt;b&gt;NHLBI Candidate-gene Association Resource.&lt;/b&gt; The NHLBI initiated the Candidate gene Association Resource (CARe) to create a shared genotype/phenotype resource for analyses of the association of genotypes with phenotypes relevant to the mission of the NHLBI. The resource comprises nine cohort studies funded by the NHLBI including: Atherosclerosis Risk in Communities (ARIC), Cardiovascular Health Study (CHS), Cleveland Family Study (CFS), Coronary Artery Risk Development in Young Adults (CARDIA), Framingham Heart Study (FHS), Jackson Heart Study (JHS), Multi-Ethnic Study of Atherosclerosis (MESA), and the Sleep Heart Health Study (SHHS). A database of genotype and phenotype data was created that includes records for approximately 41,000 study participants with approximately 50,000 SNPs from more than 2,000 selected candidate genes. In addition, a genome wide association study using a 1,000K SNP Chip was conducted on approximately 8,900 African American participants drawn from five CARe cohorts: ARIC, CARDIA, CFS, JHS, and MESA. Data from individual cohorts is available to approved investigators through dbGaP.&lt;/p&gt;   &lt;p&gt;&lt;b&gt;Some relevant CARe publications&lt;/b&gt;&lt;br/&gt;   CARe Study: PMID &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/20400780" target="_blank"&gt;20400780&lt;/a&gt;&lt;br/&gt;   CVD Chip Design: PMID &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18974833" target="_blank"&gt;18974833&lt;/a&gt;   &lt;/p&gt;   &lt;p&gt;The unflagging commitment of the research participants in the NHLBI FHS has made more than a half century of    research success possible. For decades, the FHS has made its data and DNA widely available to qualified investigators    throughout the world through the Limited Access Datasets and the FHS DNA Committee, and the CARe database will continue    that tradition by allowing access to qualified investigators who agree to the requirements of data access. With the CARe    database, we continue with an ambitious research agenda and look forward to new discoveries in the decades to come.&lt;/p&gt;
 </Description><StudyHistory>
&lt;p&gt;Research milestones of the Framingham Heart Study can be found at &lt;a href="http://www.framinghamheartstudy.org/about/milestones.html" target="_blank"&gt;http://www.framinghamheartstudy.org/about/milestones.html&lt;/a&gt;.&lt;/p&gt;   &lt;p&gt;The Generation 1 (or Original) cohort Exam 1 took place between 1948 and 1953. Biennial exams have continued to the present. Exam 29 took place between 2006 and 2007. Exam 30 began in 2008.&lt;/p&gt;   &lt;p&gt;The Generation 2 (or Offspring) cohort Exam 1 took place between 1971 and 1975. This cohort on average has been examined every three to four years. However, there was an eight year gap between Exam 1 and Exam 2 and a seven year gap between Exam 7 and Exam 8. Exam 8 took place between 2005 and 2008.&lt;/p&gt;   &lt;p&gt;The Generation 3 cohort Exam 1 took place between 2002 and 2005. Exam 2 began in 2008.&lt;/p&gt;   &lt;p&gt;The New Offspring Spouse cohort Exam 1 took place between 2003 and 2005. Exam 2 began in 2008.&lt;/p&gt;
 </StudyHistory><StudyURLs><Url name="The Framingham Heart Study" url="http://www.nhlbi.nih.gov/about/framingham/index.html"/></StudyURLs><Publications><Publication><Pubmed pmid="20400780"/></Publication><Publication><Pubmed pmid="18974833"/></Publication><Publication><Pubmed pmid="39810"/></Publication><Publication><Pubmed pmid="68118"/></Publication><Publication><Pubmed pmid="69075"/></Publication><Publication><Pubmed pmid="69778"/></Publication><Publication><Pubmed pmid="91037"/></Publication><Publication><Pubmed pmid="123182"/></Publication><Publication><Pubmed pmid="132115"/></Publication><Publication><Pubmed pmid="132862"/></Publication><Publication><Pubmed pmid="138134"/></Publication><Publication><Pubmed pmid="141882"/></Publication><Publication><Pubmed pmid="154283"/></Publication><Publication><Pubmed pmid="154870"/></Publication><Publication><Pubmed pmid="164628"/></Publication><Publication><Pubmed pmid="191215"/></Publication><Publication><Pubmed pmid="191465"/></Publication><Publication><Pubmed pmid="193398"/></Publication><Publication><Pubmed pmid="193777"/></Publication><Publication><Pubmed pmid="199096"/></Publication><Publication><Pubmed pmid="209795"/></Publication><Publication><Pubmed pmid="212996"/></Publication><Publication><Pubmed pmid="217290"/></Publication><Publication><Pubmed pmid="222500"/></Publication><Publication><Pubmed pmid="224699"/></Publication><Publication><Pubmed pmid="274986"/></Publication><Publication><Pubmed pmid="333888"/></Publication><Publication><Pubmed pmid="430798"/></Publication><Publication><Pubmed pmid="443188"/></Publication><Publication><Pubmed pmid="453046"/></Publication><Publication><Pubmed pmid="457828"/></Publication><Publication><Pubmed pmid="457833"/></Publication><Publication><Pubmed pmid="464698"/></Publication><Publication><Pubmed pmid="474565"/></Publication><Publication><Pubmed pmid="474566"/></Publication><Publication><Pubmed pmid="474567"/></Publication><Publication><Pubmed pmid="486684"/></Publication><Publication><Pubmed pmid="508073"/></Publication><Publication><Pubmed pmid="518733"/></Publication><Publication><Pubmed pmid="520114"/></Publication><Publication><Pubmed pmid="570666"/></Publication><Publication><Pubmed pmid="577575"/></Publication><Publication><Pubmed pmid="586715"/></Publication><Publication><Pubmed pmid="642745"/></Publication><Publication><Pubmed pmid="647930"/></Publication><Publication><Pubmed pmid="651576"/></Publication><Publication><Pubmed pmid="652993"/></Publication><Publication><Pubmed pmid="665654"/></Publication><Publication><Pubmed pmid="665655"/></Publication><Publication><Pubmed pmid="675263"/></Publication><Publication><Pubmed pmid="677027"/></Publication><Publication><Pubmed pmid="677576"/></Publication><Publication><Pubmed pmid="680566"/></Publication><Publication><Pubmed pmid="704796"/></Publication><Publication><Pubmed pmid="742537"/></Publication><Publication><Pubmed pmid="758126"/></Publication><Publication><Pubmed pmid="879158"/></Publication><Publication><Pubmed pmid="939793"/></Publication><Publication><Pubmed pmid="942677"/></Publication><Publication><Pubmed pmid="960151"/></Publication><Publication><Pubmed pmid="967833"/></Publication><Publication><Pubmed pmid="970770"/></Publication><Publication><Pubmed pmid="990870"/></Publication><Publication><Pubmed pmid="1008914"/></Publication><Publication><Pubmed pmid="1010660"/></Publication><Publication><Pubmed pmid="1044423"/></Publication><Publication><Pubmed pmid="1071864"/></Publication><Publication><Pubmed pmid="1071869"/></Publication><Publication><Pubmed pmid="1080450"/></Publication><Publication><Pubmed pmid="1085233"/></Publication><Publication><Pubmed pmid="1094879"/></Publication><Publication><Pubmed pmid="1096626"/></Publication><Publication><Pubmed pmid="1122043"/></Publication><Publication><Pubmed pmid="1139757"/></Publication><Publication><Pubmed pmid="1163424"/></Publication><Publication><Pubmed pmid="1178004"/></Publication><Publication><Pubmed pmid="1208363"/></Publication><Publication><Pubmed pmid="1245042"/></Publication><Publication><Pubmed pmid="1246956"/></Publication><Publication><Pubmed pmid="1258858"/></Publication><Publication><Pubmed pmid="1275621"/></Publication><Publication><Pubmed pmid="1280018"/></Publication><Publication><Pubmed pmid="1301257"/></Publication><Publication><Pubmed pmid="1303626"/></Publication><Publication><Pubmed pmid="1342256"/></Publication><Publication><Pubmed pmid="1342260"/></Publication><Publication><Pubmed pmid="1342264"/></Publication><Publication><Pubmed pmid="1342296"/></Publication><Publication><Pubmed pmid="1352975"/></Publication><Publication><Pubmed pmid="1370216"/></Publication><Publication><Pubmed pmid="1396865"/></Publication><Publication><Pubmed pmid="1397771"/></Publication><Publication><Pubmed pmid="1414914"/></Publication><Publication><Pubmed pmid="1414943"/></Publication><Publication><Pubmed pmid="1415492"/></Publication><Publication><Pubmed pmid="1420088"/></Publication><Publication><Pubmed pmid="1420849"/></Publication><Publication><Journal authors="Kannel WB, Shurtleff D" title="&quot;The natural history of arteriosclerosis obliterans&quot;" journal="Cardiovascular Clinics: Peripheral Vascular Disease. Eds. Brest AN, Gifford RW. Philadelphia: Davis FA, 1971. 3(37)-3(52)"/></Publication><Publication><Journal authors="Kannel WB, Sorlie P" title="&quot;Hypertension in Framingham&quot;" journal="Epidemiology and Control of Hypertension. Ed. Oglesby P. Miami: Symposia Specialists, 1975. 553-592"/></Publication><Publication><Journal authors="Kannel WB, Sorlie PD, Brand FN, Castelli WP, McNamara PM, Gherardi G" title="&quot;Epidemiology of coronary atherosclerosis: postmortem vs clinical risk factor correlations: the Framingham Study&quot;" journal="Artherosclerosis-V. New York: Springer-Verlag, 1980. 54-56"/></Publication><Publication><Journal authors="Kannel WB, Sorlie PD, Gill E" title="&quot;Epidemiologische aspekte der angina pectoris&quot;" journal="Angina pectoris. Pravention, Nichtoperative langzeitbehandlung und rehabilitation. Ed. Gill E. Stuttgart, New York: Gustav Fischer Verlag, 1978. 249-274"/></Publication><Publication><Journal authors="Kannel WB, Sorlie PD, McNamara PM" title="&quot;The relation of physical activity to risk of coronary heart disease. The Framingham Study&quot;" journal="Coronary Heart Disease and Physical Fitness. Proceedings of a Symposium Held in Copenhagen, September 2-5, 1970. Eds. Larsen OA, Malmborg RO. Baltimore: University Park Press, 1971. 256-260"/></Publication><Publication><Journal authors="Kannel WB, Stokes JI" title="&quot;Hypertension as a cardiovascular risk factor&quot;" journal="Handbook of Hypertension. Epidemiology of Hypertension. Ed. Bulpitt CJ. Elsevier Science Publishers B.V., 1985. 16-34"/></Publication><Publication><Journal authors="Kannel WB, Stokes JI" title="&quot;The epidemiology of coronary artery disease&quot;" journal="Diagnosis and Therapy of Coronary Artery Disease. Ed. Cohn PF. Hauge/Boston/London: Martinus Nijhoff, 1985. 63-88"/></Publication><Publication><Journal authors="Kannel WB, Thom T" title="&quot;Incidence, prevalence, and mortality of cardiovascular diseases&quot;" journal="Hurst's the Heart. Eds. Schlant RC, Alexander RW, O'Rourke RA, Roberts R, Sonnenblick EH. New York: McGraw-Hill, 1994. 185-197"/></Publication><Publication><Journal authors="Kannel WB, Thom TJ" title="&quot;Incidence, prevalence, and mortality of cardiovascular diseases&quot;" journal="The Heart. Arteries and Veins. Ed. Hurst JW. New York: McGraw-Hill Book Co., 1986. 557-565"/></Publication><Publication><Journal authors="Kannel WB, Thom TJ" title="&quot;Incidence, prevalence, and mortality of cardiovascular diseases&quot;" journal="The Heart. Arteries and Veins. Ed. Hurst JW. New York: McGraw-Hill Book Co., 1989. 627-638"/></Publication><Publication><Journal authors="Kannel WB, Ward GW" title="&quot;A decade of advances in preventive cardiology&quot;" journal="Physician Assistant. 1987. 56-78"/></Publication><Publication><Journal authors="Kannel WB, Wolf PA" title="&quot;Epidemiology of atrial fibrillation&quot;" journal="Atrial Fibrillation: Mechanisms and Management. Eds. Falk RH, Podrid PJ. New York: Raven Press, Ltd., 1992. 81-92"/></Publication><Publication><Journal authors="Levy D, Lauer MS" title="&quot;Left ventricular hypertrophy: echocardiographic assessment and prognostic implications&quot;" journal="Textbook of Echocardiography and Doppler in Adults and Children. Eds. Sutton MGSJ, Oldershaw PJ, Kotler MN. Cambridge,MA: Blackwell Science, 1996. 342-352"/></Publication><Publication><Journal authors="Levy D, Savage DD, Garrison RJ, Bailey JJ, Kannel WB, Castelli WP" title="&quot;Left ventricular hypertrophy: the Framingham Study&quot;" journal="Computerized Interpretation of the Electrocardiogram x. Proceedings of the 1985 Engineering Foundation Conference. Ed. Bailey JJ. New York: Engineering Foundation, 1986. 273-288"/></Publication><Publication><Journal authors="Levy D, Wilson PWF" title="&quot;Atherosclerotic cardiovascular disease:an epidemiologic perspective&quot;" journal="Text of Cardiovascular Medicine. Ed. Topol EJ. Philadelphia: Lippincott-Raven, 1998. 13-30"/></Publication><Publication><Journal authors="Stokes JI, Garrison RJ, Kannel WB" title="&quot;The independent contributions of various indices of obesity to the 22-year incidence of coronary heart disease: the Framingham Heart Study&quot;" journal="Metabolic Complictaions of Human Obesities. Ed. Vague J. Elsevier science publishers B.V. (Biomedical Division), 1985. 49-57"/></Publication><Publication><Journal authors="Thomas HE, Kannel WB" title="&quot;Diabetes and prevention of coronary heart disease&quot;" journal="Primary Prevention of Coronary Heart Disease: A Practical Guide for the Clinician. Eds. Podell RN, Stewart MM. Menlo Park: Addison-Wesley Publishing Co., 1984. 150-170"/></Publication><Publication><Journal authors="Vasan RS, Levy D" title="&quot;The progression from hypertension to heart failure:an overview of pathogenetic mechanisms&quot;" journal="Controversies in the Management of Heart Failure. Ed. Coats A. New York: Churchill Livingstone, 1997. 1-10"/></Publication><Publication><Journal authors="Vokonas PS, Kannel WB" title="&quot;Diabetes mellitus and coronary heart disease in the elderly&quot;" journal="Clinics in Geriatric Medicine. Eds. Wilbert S.Aronow, Donald D.Tresch. Philadelphia: WB Saunders Co., 1996. 69-78"/></Publication><Publication><Journal authors="Vokonas PS, Kannel WB" title="&quot;Risk factors for and prevention of atherosclerotic cardiovascular disease&quot;" journal="Current Practice of Medicine. Eds. Sapira JD, Alpert JS, Bone RC, Korenman SG. New York: Churchill Livingstone, 1996. 7.1-7.1"/></Publication><Publication><Journal authors="Wilson PWF" title="&quot;Importance of lipid fractions for coronary morbidity and mortality&quot;" journal="Colloque International. Eds. Capron L, Detilleux M, Sachet P. Paris: 1990. 73-79"/></Publication><Publication><Journal authors="Wilson PWF, Anderson KM" title="&quot;HDL cholesterol and triglycerides as risk factors for CHD&quot;" journal="Atherosclerosis and Cardiovascular Disease. Eds. Gaddi DA, Lenzi M, Lenzi S. Dordrecht: Kluwer academic publishers, 1990. 609-615"/></Publication><Publication><Journal authors="Wilson PWF, Anderson KM, Castelli WP" title="&quot;The impact of triglycerides on coronary heart disease: the Framingham Study&quot;" journal="Atherosclerosis Review. Eds. Gotto AM, Paoletti R. New York: Ravin Press, 1991. 59-63"/></Publication><Publication><Journal authors="Wilson PWF, Castelli WP" title="&quot;Coronary heart disease: the view from Framingham&quot;" journal="Coronary Risk Factors Revisited. Ed. Shepherd J. Dublin: Elsevier Science Publishers B.V., 1989. 3-14"/></Publication><Publication><Journal authors="Wilson PWF, Kannel WB" title="&quot;Epidemiology of hyperglycemia and atherosclerosis&quot;" journal="Hyperglycemia, Diabetes, and Vascular Disease. Ed. Ruderman N. New York: Oxford University Press, 1992. 21-29"/></Publication><Publication><Journal authors="Wolf PA" title="&quot;Hypertension as a risk factor for stroke&quot;" journal="Cerebral Vascular Diseases. Eds. Whisnant JP, Sandok B. New York: Grune and Stratton, 1975. 105-112"/></Publication><Publication><Journal authors="Wolf PA" title="&quot;Epidemiology of Stroke&quot;" journal="Stroke, Pathophysiology, Diagnosis, and Management, 4th Edition. Eds. Mohr JP, Choi DW, Grotta JC, Wolf PA. Elsevier Publishing, 2004. 13-34"/></Publication><Publication><Journal authors="Wolf PA, Belanger AJ, D'Agostino RB" title="&quot;Management of risk factors&quot;" journal="Neurologic Clinics. Eds. Barnett HJM, Hachinski VC. Philadelphia: Harcourt Brace Jovanovich,Inc., 1992. 177-191"/></Publication><Publication><Journal authors="Wolf PA, Dawber TR, Thomas HE, Colton T, Kannel WB" title="&quot;Epidemiology of stroke&quot;" journal="Advances in Neurology: Stroke. Eds. Thompson RA, Green JR. New York: Raven Press, Vol. 16, 1977. 5-19"/></Publication><Publication><Journal authors="Wolf PA, Kannel WB, Verter JI" title="&quot;Epidemiologic appraisal of hypertension and stroke risk&quot;" journal="Hypertension and the Brain. Eds. Guthrie GP, Kotchen TA. New York: Futura Publishing Co., 1984. 221-246"/></Publication><Publication><Pubmed pmid="1440701"/></Publication><Publication><Pubmed pmid="1442588"/></Publication><Publication><Pubmed pmid="1450174"/></Publication><Publication><Pubmed pmid="1466315"/></Publication><Publication><Pubmed pmid="1486903"/></Publication><Publication><Pubmed pmid="1503074"/></Publication><Publication><Pubmed pmid="1514505"/></Publication><Publication><Pubmed pmid="1515981"/></Publication><Publication><Pubmed pmid="1517906"/></Publication><Publication><Pubmed pmid="1518109"/></Publication><Publication><Pubmed pmid="1519533"/></Publication><Publication><Pubmed pmid="1519536"/></Publication><Publication><Pubmed pmid="1530806"/></Publication><Publication><Pubmed pmid="1531786"/></Publication><Publication><Pubmed pmid="1531990"/></Publication><Publication><Pubmed pmid="1533995"/></Publication><Publication><Pubmed pmid="1534286"/></Publication><Publication><Pubmed pmid="1538564"/></Publication><Publication><Pubmed pmid="1543306"/></Publication><Publication><Pubmed pmid="1543692"/></Publication><Publication><Pubmed pmid="1558342"/></Publication><Publication><Pubmed pmid="1569437"/></Publication><Publication><Pubmed pmid="1573433"/></Publication><Publication><Pubmed pmid="1576223"/></Publication><Publication><Pubmed pmid="1585898"/></Publication><Publication><Pubmed pmid="1595694"/></Publication><Publication><Pubmed pmid="1607574"/></Publication><Publication><Pubmed pmid="1625711"/></Publication><Publication><Pubmed pmid="1638580"/></Publication><Publication><Pubmed pmid="1642190"/></Publication><Publication><Pubmed pmid="1678604"/></Publication><Publication><Pubmed pmid="1684707"/></Publication><Publication><Pubmed pmid="1715449"/></Publication><Publication><Pubmed pmid="1727952"/></Publication><Publication><Pubmed pmid="1729324"/></Publication><Publication><Pubmed pmid="1729846"/></Publication><Publication><Pubmed pmid="1733810"/></Publication><Publication><Pubmed pmid="1734291"/></Publication><Publication><Pubmed pmid="1749738"/></Publication><Publication><Pubmed pmid="1765986"/></Publication><Publication><Pubmed pmid="1783233"/></Publication><Publication><Pubmed pmid="1825213"/></Publication><Publication><Pubmed pmid="1827234"/></Publication><Publication><Pubmed pmid="1829117"/></Publication><Publication><Pubmed pmid="1833430"/></Publication><Publication><Pubmed pmid="1833977"/></Publication><Publication><Pubmed pmid="1838765"/></Publication><Publication><Pubmed pmid="1838769"/></Publication><Publication><Pubmed pmid="1845934"/></Publication><Publication><Pubmed pmid="1864700"/></Publication><Publication><Pubmed pmid="1866765"/></Publication><Publication><Pubmed pmid="1912805"/></Publication><Publication><Pubmed pmid="1929036"/></Publication><Publication><Pubmed pmid="1969567"/></Publication><Publication><Pubmed pmid="1972879"/></Publication><Publication><Pubmed pmid="1984536"/></Publication><Publication><Pubmed pmid="1984895"/></Publication><Publication><Pubmed pmid="1985385"/></Publication><Publication><Pubmed pmid="1985591"/></Publication><Publication><Pubmed pmid="1986505"/></Publication><Publication><Pubmed pmid="1986576"/></Publication><Publication><Pubmed pmid="1986979"/></Publication><Publication><Pubmed pmid="1990765"/></Publication><Publication><Pubmed pmid="1993947"/></Publication><Publication><Pubmed pmid="1995775"/></Publication><Publication><Pubmed pmid="1999037"/></Publication><Publication><Pubmed pmid="2000773"/></Publication><Publication><Pubmed pmid="2003298"/></Publication><Publication><Pubmed pmid="2003301"/></Publication><Publication><Pubmed pmid="2006650"/></Publication><Publication><Pubmed pmid="2008855"/></Publication><Publication><Pubmed pmid="2035438"/></Publication><Publication><Pubmed pmid="2037857"/></Publication><Publication><Pubmed pmid="2039382"/></Publication><Publication><Pubmed pmid="2041550"/></Publication><Publication><Pubmed pmid="2043019"/></Publication><Publication><Pubmed pmid="2043309"/></Publication><Publication><Pubmed pmid="2058564"/></Publication><Publication><Pubmed pmid="2064487"/></Publication><Publication><Pubmed pmid="2065030"/></Publication><Publication><Pubmed pmid="2068909"/></Publication><Publication><Pubmed pmid="2083986"/></Publication><Publication><Pubmed pmid="2120547"/></Publication><Publication><Pubmed pmid="2136875"/></Publication><Publication><Pubmed pmid="2137280"/></Publication><Publication><Pubmed pmid="2137733"/></Publication><Publication><Pubmed pmid="2137960"/></Publication><Publication><Pubmed pmid="2139921"/></Publication><Publication><Pubmed pmid="2142690"/></Publication><Publication><Pubmed pmid="2148709"/></Publication><Publication><Pubmed pmid="2150470"/></Publication><Publication><Pubmed pmid="2151041"/></Publication><Publication><Pubmed pmid="2203248"/></Publication><Publication><Pubmed pmid="2206030"/></Publication><Publication><Pubmed pmid="2210098"/></Publication><Publication><Pubmed pmid="2219557"/></Publication><Publication><Pubmed pmid="2220449"/></Publication><Publication><Pubmed pmid="2220549"/></Publication><Publication><Pubmed pmid="2220632"/></Publication><Publication><Pubmed pmid="2220800"/></Publication><Publication><Pubmed pmid="2229757"/></Publication><Publication><Pubmed pmid="2239671"/></Publication><Publication><Pubmed pmid="2240306"/></Publication><Publication><Pubmed pmid="2281238"/></Publication><Publication><Pubmed pmid="2286855"/></Publication><Publication><Pubmed pmid="2287948"/></Publication><Publication><Pubmed pmid="2288563"/></Publication><Publication><Pubmed pmid="2289404"/></Publication><Publication><Pubmed pmid="2297935"/></Publication><Publication><Pubmed pmid="2299677"/></Publication><Publication><Pubmed pmid="2304240"/></Publication><Publication><Pubmed pmid="2306830"/></Publication><Publication><Pubmed pmid="2324788"/></Publication><Publication><Pubmed pmid="2327425"/></Publication><Publication><Pubmed pmid="2328031"/></Publication><Publication><Pubmed pmid="2340509"/></Publication><Publication><Pubmed pmid="2356805"/></Publication><Publication><Pubmed pmid="2368855"/></Publication><Publication><Pubmed pmid="2377595"/></Publication><Publication><Pubmed pmid="2379929"/></Publication><Publication><Pubmed pmid="2389702"/></Publication><Publication><Pubmed pmid="2391060"/></Publication><Publication><Pubmed pmid="2392975"/></Publication><Publication><Pubmed pmid="2393034"/></Publication><Publication><Pubmed pmid="2403108"/></Publication><Publication><Pubmed pmid="2468976"/></Publication><Publication><Pubmed pmid="2485019"/></Publication><Publication><Pubmed pmid="2490832"/></Publication><Publication><Pubmed pmid="2521199"/></Publication><Publication><Pubmed pmid="2523187"/></Publication><Publication><Pubmed pmid="2523239"/></Publication><Publication><Pubmed pmid="2527287"/></Publication><Publication><Pubmed pmid="2530879"/></Publication><Publication><Pubmed pmid="2533234"/></Publication><Publication><Pubmed pmid="2535213"/></Publication><Publication><Pubmed pmid="2542911"/></Publication><Publication><Pubmed pmid="2556099"/></Publication><Publication><Pubmed pmid="2573262"/></Publication><Publication><Pubmed pmid="2591979"/></Publication><Publication><Pubmed pmid="2607526"/></Publication><Publication><Pubmed pmid="2634108"/></Publication><Publication><Pubmed pmid="2642759"/></Publication><Publication><Pubmed pmid="2644027"/></Publication><Publication><Pubmed pmid="2652106"/></Publication><Publication><Pubmed pmid="2679085"/></Publication><Publication><Pubmed pmid="2705374"/></Publication><Publication><Pubmed pmid="2709545"/></Publication><Publication><Pubmed pmid="2715555"/></Publication><Publication><Pubmed pmid="2719508"/></Publication><Publication><Pubmed pmid="2725273"/></Publication><Publication><Pubmed pmid="2733123"/></Publication><Publication><Pubmed pmid="2738308"/></Publication><Publication><Pubmed pmid="2749843"/></Publication><Publication><Pubmed pmid="2763992"/></Publication><Publication><Pubmed pmid="2764375"/></Publication><Publication><Pubmed pmid="2782245"/></Publication><Publication><Pubmed pmid="2784619"/></Publication><Publication><Pubmed pmid="2807709"/></Publication><Publication><Pubmed pmid="2810282"/></Publication><Publication><Pubmed pmid="2898205"/></Publication><Publication><Pubmed pmid="2908919"/></Publication><Publication><Pubmed pmid="2910074"/></Publication><Publication><Pubmed pmid="2911981"/></Publication><Publication><Pubmed pmid="2913738"/></Publication><Publication><Pubmed pmid="2919539"/></Publication><Publication><Pubmed pmid="2920052"/></Publication><Publication><Pubmed pmid="2925008"/></Publication><Publication><Pubmed pmid="2936230"/></Publication><Publication><Pubmed pmid="2947749"/></Publication><Publication><Pubmed pmid="2952002"/></Publication><Publication><Pubmed pmid="2954993"/></Publication><Publication><Pubmed pmid="2957907"/></Publication><Publication><Pubmed pmid="2961250"/></Publication><Publication><Pubmed pmid="2962527"/></Publication><Publication><Pubmed pmid="2971099"/></Publication><Publication><Pubmed pmid="2971709"/></Publication><Publication><Pubmed pmid="2974889"/></Publication><Publication><Pubmed pmid="2975214"/></Publication><Publication><Pubmed pmid="2995808"/></Publication><Publication><Pubmed pmid="3042200"/></Publication><Publication><Pubmed pmid="3054902"/></Publication><Publication><Pubmed pmid="3066625"/></Publication><Publication><Pubmed pmid="3081805"/></Publication><Publication><Pubmed pmid="3113392"/></Publication><Publication><Pubmed pmid="3116009"/></Publication><Publication><Pubmed pmid="3154646"/></Publication><Publication><Pubmed pmid="3155483"/></Publication><Publication><Pubmed pmid="3158191"/></Publication><Publication><Pubmed pmid="3161323"/></Publication><Publication><Pubmed pmid="3164971"/></Publication><Publication><Pubmed pmid="3179802"/></Publication><Publication><Pubmed pmid="3185666"/></Publication><Publication><Pubmed pmid="3185900"/></Publication><Publication><Pubmed pmid="3189175"/></Publication><Publication><Pubmed pmid="3189283"/></Publication><Publication><Pubmed pmid="3195432"/></Publication><Publication><Pubmed pmid="3196218"/></Publication><Publication><Pubmed pmid="3210285"/></Publication><Publication><Pubmed pmid="3216240"/></Publication><Publication><Pubmed pmid="3259405"/></Publication><Publication><Pubmed pmid="3279346"/></Publication><Publication><Pubmed pmid="3280493"/></Publication><Publication><Pubmed pmid="3293436"/></Publication><Publication><Pubmed pmid="3298365"/></Publication><Publication><Pubmed pmid="3300233"/></Publication><Publication><Pubmed pmid="3310026"/></Publication><Publication><Pubmed pmid="3332428"/></Publication><Publication><Pubmed pmid="3339376"/></Publication><Publication><Pubmed pmid="3339789"/></Publication><Publication><Pubmed pmid="3339799"/></Publication><Publication><Pubmed pmid="3353604"/></Publication><Publication><Pubmed pmid="3354416"/></Publication><Publication><Pubmed pmid="3370018"/></Publication><Publication><Pubmed pmid="3376575"/></Publication><Publication><Pubmed pmid="3377033"/></Publication><Publication><Pubmed pmid="3377350"/></Publication><Publication><Pubmed pmid="3377666"/></Publication><Publication><Pubmed pmid="3379134"/></Publication><Publication><Pubmed pmid="3394638"/></Publication><Publication><Pubmed pmid="3395496"/></Publication><Publication><Pubmed pmid="3440109"/></Publication><Publication><Pubmed pmid="3452820"/></Publication><Publication><Pubmed pmid="3452822"/></Publication><Publication><Pubmed pmid="3493089"/></Publication><Publication><Pubmed pmid="3496348"/></Publication><Publication><Pubmed pmid="3500729"/></Publication><Publication><Pubmed pmid="3500994"/></Publication><Publication><Pubmed pmid="3510241"/></Publication><Publication><Pubmed pmid="3538839"/></Publication><Publication><Pubmed pmid="3544787"/></Publication><Publication><Pubmed pmid="3554946"/></Publication><Publication><Pubmed pmid="3554948"/></Publication><Publication><Pubmed pmid="3560398"/></Publication><Publication><Pubmed pmid="3565227"/></Publication><Publication><Pubmed pmid="3565356"/></Publication><Publication><Pubmed pmid="3568338"/></Publication><Publication><Pubmed pmid="3585172"/></Publication><Publication><Pubmed pmid="3588564"/></Publication><Publication><Pubmed pmid="3591616"/></Publication><Publication><Pubmed pmid="3591674"/></Publication><Publication><Pubmed pmid="3597679"/></Publication><Publication><Pubmed pmid="3597695"/></Publication><Publication><Pubmed pmid="3604900"/></Publication><Publication><Pubmed pmid="3626001"/></Publication><Publication><Pubmed pmid="3628637"/></Publication><Publication><Pubmed pmid="3632164"/></Publication><Publication><Pubmed pmid="3632732"/></Publication><Publication><Pubmed pmid="3657888"/></Publication><Publication><Pubmed pmid="3661384"/></Publication><Publication><Pubmed pmid="3661393"/></Publication><Publication><Pubmed pmid="3665963"/></Publication><Publication><Pubmed pmid="3669619"/></Publication><Publication><Pubmed pmid="3675308"/></Publication><Publication><Pubmed pmid="3679841"/></Publication><Publication><Pubmed pmid="3681146"/></Publication><Publication><Pubmed pmid="3687920"/></Publication><Publication><Pubmed pmid="3706387"/></Publication><Publication><Pubmed pmid="3706388"/></Publication><Publication><Pubmed pmid="3720271"/></Publication><Publication><Pubmed pmid="3720567"/></Publication><Publication><Pubmed pmid="3739899"/></Publication><Publication><Pubmed pmid="3740047"/></Publication><Publication><Pubmed pmid="3762621"/></Publication><Publication><Pubmed pmid="3766383"/></Publication><Publication><Pubmed pmid="3773200"/></Publication><Publication><Pubmed pmid="3776801"/></Publication><Publication><Pubmed pmid="3779719"/></Publication><Publication><Pubmed pmid="3804399"/></Publication><Publication><Pubmed pmid="3812192"/></Publication><Publication><Pubmed pmid="3812193"/></Publication><Publication><Pubmed pmid="3815783"/></Publication><Publication><Pubmed pmid="3815784"/></Publication><Publication><Pubmed pmid="3820463"/></Publication><Publication><Pubmed pmid="3823665"/></Publication><Publication><Pubmed pmid="3825868"/></Publication><Publication><Pubmed pmid="3825946"/></Publication><Publication><Pubmed pmid="3833369"/></Publication><Publication><Pubmed pmid="3885703"/></Publication><Publication><Pubmed pmid="3889106"/></Publication><Publication><Pubmed pmid="3946178"/></Publication><Publication><Pubmed pmid="3946458"/></Publication><Publication><Pubmed pmid="3947296"/></Publication><Publication><Pubmed pmid="3949940"/></Publication><Publication><Pubmed pmid="3953550"/></Publication><Publication><Pubmed pmid="3964720"/></Publication><Publication><Pubmed pmid="3964986"/></Publication><Publication><Pubmed pmid="3965550"/></Publication><Publication><Pubmed pmid="3976481"/></Publication><Publication><Pubmed pmid="3980054"/></Publication><Publication><Pubmed pmid="4014135"/></Publication><Publication><Pubmed pmid="4023480"/></Publication><Publication><Pubmed pmid="4024175"/></Publication><Publication><Pubmed pmid="4026469"/></Publication><Publication><Pubmed pmid="4043571"/></Publication><Publication><Pubmed pmid="4045086"/></Publication><Publication><Pubmed pmid="4058547"/></Publication><Publication><Pubmed pmid="4061265"/></Publication><Publication><Pubmed pmid="4062116"/></Publication><Publication><Pubmed pmid="4068186"/></Publication><Publication><Pubmed pmid="4088270"/></Publication><Publication><Pubmed pmid="4129874"/></Publication><Publication><Pubmed pmid="4143310"/></Publication><Publication><Pubmed pmid="4184130"/></Publication><Publication><Pubmed pmid="4239887"/></Publication><Publication><Pubmed pmid="4247338"/></Publication><Publication><Pubmed pmid="4261794"/></Publication><Publication><Pubmed pmid="4261853"/></Publication><Publication><Pubmed pmid="4262573"/></Publication><Publication><Pubmed pmid="4264724"/></Publication><Publication><Pubmed pmid="4275471"/></Publication><Publication><Pubmed pmid="4276031"/></Publication><Publication><Pubmed pmid="4338292"/></Publication><Publication><Pubmed pmid="4359625"/></Publication><Publication><Pubmed pmid="4412497"/></Publication><Publication><Pubmed pmid="4429452"/></Publication><Publication><Pubmed pmid="4432249"/></Publication><Publication><Pubmed pmid="4436425"/></Publication><Publication><Pubmed pmid="4447106"/></Publication><Publication><Pubmed pmid="4552435"/></Publication><Publication><Pubmed pmid="4647218"/></Publication><Publication><Pubmed pmid="4670405"/></Publication><Publication><Pubmed pmid="4683662"/></Publication><Publication><Pubmed pmid="4699520"/></Publication><Publication><Pubmed pmid="4713110"/></Publication><Publication><Pubmed pmid="4721742"/></Publication><Publication><Pubmed pmid="4814834"/></Publication><Publication><Pubmed pmid="4824624"/></Publication><Publication><Pubmed pmid="4830839"/></Publication><Publication><Pubmed pmid="4830844"/></Publication><Publication><Pubmed pmid="4835750"/></Publication><Publication><Pubmed pmid="4937603"/></Publication><Publication><Pubmed pmid="5058341"/></Publication><Publication><Pubmed pmid="5060500"/></Publication><Publication><Pubmed pmid="5095238"/></Publication><Publication><Pubmed pmid="5107681"/></Publication><Publication><Pubmed pmid="5113790"/></Publication><Publication><Pubmed pmid="5122894"/></Publication><Publication><Pubmed pmid="5136232"/></Publication><Publication><Pubmed pmid="5253784"/></Publication><Publication><Pubmed pmid="5411048"/></Publication><Publication><Pubmed pmid="5418553"/></Publication><Publication><Pubmed pmid="5439413"/></Publication><Publication><Pubmed pmid="5444530"/></Publication><Publication><Pubmed pmid="5469068"/></Publication><Publication><Pubmed pmid="5534972"/></Publication><Publication><Pubmed pmid="5539274"/></Publication><Publication><Pubmed pmid="5572576"/></Publication><Publication><Pubmed pmid="5633266"/></Publication><Publication><Pubmed pmid="5671419"/></Publication><Publication><Pubmed pmid="5673172"/></Publication><Publication><Pubmed pmid="5770006"/></Publication><Publication><Pubmed pmid="5789839"/></Publication><Publication><Pubmed pmid="5804986"/></Publication><Publication><Pubmed pmid="5804989"/></Publication><Publication><Pubmed pmid="5857751"/></Publication><Publication><Pubmed pmid="5859556"/></Publication><Publication><Pubmed pmid="5900203"/></Publication><Publication><Pubmed pmid="5908872"/></Publication><Publication><Pubmed pmid="5910970"/></Publication><Publication><Pubmed pmid="5921755"/></Publication><Publication><Pubmed pmid="5933418"/></Publication><Publication><Pubmed pmid="5966010"/></Publication><Publication><Pubmed pmid="6016478"/></Publication><Publication><Pubmed pmid="6020881"/></Publication><Publication><Pubmed pmid="6024013"/></Publication><Publication><Pubmed pmid="6028270"/></Publication><Publication><Pubmed pmid="6028658"/></Publication><Publication><Pubmed pmid="6049533"/></Publication><Publication><Pubmed pmid="6065137"/></Publication><Publication><Pubmed pmid="6066539"/></Publication><Publication><Pubmed pmid="6067346"/></Publication><Publication><Pubmed pmid="6113480"/></Publication><Publication><Pubmed pmid="6124768"/></Publication><Publication><Pubmed pmid="6208888"/></Publication><Publication><Pubmed pmid="6219830"/></Publication><Publication><Pubmed pmid="6220597"/></Publication><Publication><Pubmed pmid="6226193"/></Publication><Publication><Pubmed pmid="6227757"/></Publication><Publication><Pubmed pmid="6229811"/></Publication><Publication><Pubmed pmid="6239541"/></Publication><Publication><Pubmed pmid="6280494"/></Publication><Publication><Pubmed pmid="6409277"/></Publication><Publication><Pubmed pmid="6452050"/></Publication><Publication><Pubmed pmid="6469411"/></Publication><Publication><Pubmed pmid="6470354"/></Publication><Publication><Pubmed pmid="6472815"/></Publication><Publication><Pubmed pmid="6477302"/></Publication><Publication><Pubmed pmid="6481055"/></Publication><Publication><Pubmed pmid="6486020"/></Publication><Publication><Pubmed pmid="6496291"/></Publication><Publication><Pubmed pmid="6499693"/></Publication><Publication><Pubmed pmid="6519901"/></Publication><Publication><Pubmed pmid="6539860"/></Publication><Publication><Pubmed pmid="6539918"/></Publication><Publication><Pubmed pmid="6573877"/></Publication><Publication><Pubmed pmid="6573878"/></Publication><Publication><Pubmed pmid="6577783"/></Publication><Publication><Pubmed pmid="6621370"/></Publication><Publication><Pubmed pmid="6637784"/></Publication><Publication><Pubmed pmid="6658948"/></Publication><Publication><Pubmed pmid="6658986"/></Publication><Publication><Pubmed pmid="6680164"/></Publication><Publication><Pubmed pmid="6702862"/></Publication><Publication><Pubmed pmid="6720566"/></Publication><Publication><Pubmed pmid="6720678"/></Publication><Publication><Pubmed pmid="6741928"/></Publication><Publication><Pubmed pmid="6823813"/></Publication><Publication><Pubmed pmid="6825228"/></Publication><Publication><Pubmed pmid="6834617"/></Publication><Publication><Pubmed pmid="6837419"/></Publication><Publication><Pubmed pmid="6837609"/></Publication><Publication><Pubmed pmid="6846165"/></Publication><Publication><Pubmed pmid="6849323"/></Publication><Publication><Pubmed pmid="6859053"/></Publication><Publication><Pubmed pmid="6869222"/></Publication><Publication><Pubmed pmid="6869360"/></Publication><Publication><Pubmed pmid="6869362"/></Publication><Publication><Pubmed pmid="6870410"/></Publication><Publication><Pubmed pmid="6881031"/></Publication><Publication><Pubmed pmid="6881032"/></Publication><Publication><Pubmed pmid="6881033"/></Publication><Publication><Pubmed pmid="6881126"/></Publication><Publication><Pubmed pmid="6881131"/></Publication><Publication><Pubmed pmid="6946880"/></Publication><Publication><Pubmed pmid="6953401"/></Publication><Publication><Pubmed pmid="6957662"/></Publication><Publication><Pubmed pmid="6968100"/></Publication><Publication><Pubmed pmid="6982544"/></Publication><Publication><Pubmed pmid="7008566"/></Publication><Publication><Pubmed pmid="7044082"/></Publication><Publication><Pubmed pmid="7044245"/></Publication><Publication><Pubmed pmid="7057572"/></Publication><Publication><Pubmed pmid="7058722"/></Publication><Publication><Pubmed pmid="7058780"/></Publication><Publication><Pubmed pmid="7058782"/></Publication><Publication><Pubmed pmid="7062992"/></Publication><Publication><Pubmed pmid="7080120"/></Publication><Publication><Pubmed pmid="7092647"/></Publication><Publication><Pubmed pmid="7099559"/></Publication><Publication><Pubmed pmid="7124663"/></Publication><Publication><Pubmed pmid="7147296"/></Publication><Publication><Pubmed pmid="7168181"/></Publication><Publication><Pubmed pmid="7183081"/></Publication><Publication><Pubmed pmid="7206111"/></Publication><Publication><Pubmed pmid="7206146"/></Publication><Publication><Pubmed pmid="7211996"/></Publication><Publication><Pubmed pmid="7236096"/></Publication><Publication><Pubmed pmid="7246530"/></Publication><Publication><Pubmed pmid="7259370"/></Publication><Publication><Pubmed pmid="7294261"/></Publication><Publication><Pubmed pmid="7294262"/></Publication><Publication><Pubmed pmid="7304597"/></Publication><Publication><Pubmed pmid="7331181"/></Publication><Publication><Pubmed pmid="7342099"/></Publication><Publication><Pubmed pmid="7350871"/></Publication><Publication><Pubmed pmid="7352459"/></Publication><Publication><Pubmed pmid="7352607"/></Publication><Publication><Pubmed pmid="7355742"/></Publication><Publication><Pubmed pmid="7357712"/></Publication><Publication><Pubmed pmid="7358823"/></Publication><Publication><Pubmed pmid="7365956"/></Publication><Publication><Pubmed pmid="7371130"/></Publication><Publication><Pubmed pmid="7371131"/></Publication><Publication><Pubmed pmid="7386451"/></Publication><Publication><Pubmed pmid="7395962"/></Publication><Publication><Pubmed pmid="7410523"/></Publication><Publication><Pubmed pmid="7414504"/></Publication><Publication><Pubmed pmid="7416024"/></Publication><Publication><Pubmed pmid="7432169"/></Publication><Publication><Pubmed pmid="7444756"/></Publication><Publication><Pubmed pmid="7447769"/></Publication><Publication><Pubmed pmid="7452849"/></Publication><Publication><Pubmed pmid="7460234"/></Publication><Publication><Pubmed pmid="7481206"/></Publication><Publication><Pubmed pmid="7481207"/></Publication><Publication><Pubmed pmid="7481208"/></Publication><Publication><Pubmed pmid="7484838"/></Publication><Publication><Pubmed pmid="7488329"/></Publication><Publication><Pubmed pmid="7488333"/></Publication><Publication><Pubmed pmid="7498406"/></Publication><Publication><Pubmed pmid="7503118"/></Publication><Publication><Pubmed pmid="7503343"/></Publication><Publication><Pubmed pmid="7518645"/></Publication><Publication><Pubmed pmid="7548359"/></Publication><Publication><Pubmed pmid="7554178"/></Publication><Publication><Pubmed pmid="7560595"/></Publication><Publication><Pubmed pmid="7572691"/></Publication><Publication><Pubmed pmid="7572959"/></Publication><Publication><Pubmed pmid="7572980"/></Publication><Publication><Pubmed pmid="7575700"/></Publication><Publication><Pubmed pmid="7584927"/></Publication><Publication><Pubmed pmid="7586324"/></Publication><Publication><Pubmed pmid="7594087"/></Publication><Publication><Pubmed pmid="7605381"/></Publication><Publication><Pubmed pmid="7631334"/></Publication><Publication><Pubmed pmid="7641364"/></Publication><Publication><Pubmed pmid="7660392"/></Publication><Publication><Pubmed pmid="7674694"/></Publication><Publication><Pubmed pmid="7675231"/></Publication><Publication><Pubmed pmid="7677127"/></Publication><Publication><Pubmed pmid="7692148"/></Publication><Publication><Pubmed pmid="7707599"/></Publication><Publication><Pubmed pmid="7717358"/></Publication><Publication><Pubmed pmid="7718731"/></Publication><Publication><Pubmed pmid="7722204"/></Publication><Publication><Pubmed pmid="7722571"/></Publication><Publication><Pubmed pmid="7733439"/></Publication><Publication><Pubmed pmid="7733843"/></Publication><Publication><Pubmed pmid="7768556"/></Publication><Publication><Pubmed pmid="7802521"/></Publication><Publication><Pubmed pmid="7813073"/></Publication><Publication><Pubmed pmid="7816063"/></Publication><Publication><Pubmed pmid="7828301"/></Publication><Publication><Pubmed pmid="7852683"/></Publication><Publication><Pubmed pmid="7884091"/></Publication><Publication><Pubmed pmid="7895352"/></Publication><Publication><Pubmed pmid="7923652"/></Publication><Publication><Pubmed pmid="7923663"/></Publication><Publication><Pubmed pmid="7935681"/></Publication><Publication><Pubmed pmid="7942478"/></Publication><Publication><Pubmed pmid="7942491"/></Publication><Publication><Pubmed pmid="7942585"/></Publication><Publication><Pubmed pmid="7942761"/></Publication><Publication><Pubmed pmid="7946184"/></Publication><Publication><Pubmed pmid="7946754"/></Publication><Publication><Pubmed pmid="7955180"/></Publication><Publication><Pubmed pmid="7960017"/></Publication><Publication><Pubmed pmid="7963277"/></Publication><Publication><Pubmed pmid="7966894"/></Publication><Publication><Pubmed pmid="7987032"/></Publication><Publication><Pubmed pmid="8007076"/></Publication><Publication><Pubmed pmid="8014388"/></Publication><Publication><Pubmed pmid="8017332"/></Publication><Publication><Pubmed pmid="8018666"/></Publication><Publication><Pubmed pmid="8025994"/></Publication><Publication><Pubmed pmid="8044959"/></Publication><Publication><Pubmed pmid="8059731"/></Publication><Publication><Pubmed pmid="8067349"/></Publication><Publication><Pubmed pmid="8071601"/></Publication><Publication><Pubmed pmid="8071609"/></Publication><Publication><Pubmed pmid="8093585"/></Publication><Publication><Pubmed pmid="8114238"/></Publication><Publication><Pubmed pmid="8122618"/></Publication><Publication><Pubmed pmid="8129049"/></Publication><Publication><Pubmed pmid="8133587"/></Publication><Publication><Pubmed pmid="8144282"/></Publication><Publication><Pubmed pmid="8160224"/></Publication><Publication><Pubmed pmid="8166127"/></Publication><Publication><Pubmed pmid="8167820"/></Publication><Publication><Pubmed pmid="8187239"/></Publication><Publication><Pubmed pmid="8197990"/></Publication><Publication><Pubmed pmid="8208397"/></Publication><Publication><Pubmed pmid="8213741"/></Publication><Publication><Pubmed pmid="8215723"/></Publication><Publication><Pubmed pmid="8230620"/></Publication><Publication><Pubmed pmid="8237811"/></Publication><Publication><Pubmed pmid="8247055"/></Publication><Publication><Pubmed pmid="8249841"/></Publication><Publication><Pubmed pmid="8250986"/></Publication><Publication><Pubmed pmid="8252666"/></Publication><Publication><Pubmed pmid="8266381"/></Publication><Publication><Pubmed pmid="8267704"/></Publication><Publication><Pubmed pmid="8268875"/></Publication><Publication><Pubmed pmid="8275219"/></Publication><Publication><Pubmed pmid="8284975"/></Publication><Publication><Pubmed pmid="8297537"/></Publication><Publication><Pubmed pmid="8310187"/></Publication><Publication><Pubmed pmid="8311963"/></Publication><Publication><Pubmed pmid="8313561"/></Publication><Publication><Pubmed pmid="8319323"/></Publication><Publication><Pubmed pmid="8324776"/></Publication><Publication><Pubmed pmid="8342510"/></Publication><Publication><Pubmed pmid="8347365"/></Publication><Publication><Pubmed pmid="8362432"/></Publication><Publication><Pubmed pmid="8363211"/></Publication><Publication><Pubmed pmid="8366158"/></Publication><Publication><Pubmed pmid="8376698"/></Publication><Publication><Pubmed pmid="8377776"/></Publication><Publication><Pubmed pmid="8391793"/></Publication><Publication><Pubmed pmid="8395477"/></Publication><Publication><Pubmed pmid="8399079"/></Publication><Publication><Pubmed pmid="8409049"/></Publication><Publication><Pubmed pmid="8409095"/></Publication><Publication><Pubmed pmid="8411593"/></Publication><Publication><Pubmed pmid="8412782"/></Publication><Publication><Pubmed pmid="8427145"/></Publication><Publication><Pubmed pmid="8427676"/></Publication><Publication><Pubmed pmid="8427768"/></Publication><Publication><Pubmed pmid="8438716"/></Publication><Publication><Pubmed pmid="8450993"/></Publication><Publication><Pubmed pmid="8462142"/></Publication><Publication><Pubmed pmid="8465742"/></Publication><Publication><Pubmed pmid="8465743"/></Publication><Publication><Pubmed pmid="8475012"/></Publication><Publication><Pubmed pmid="8480674"/></Publication><Publication><Pubmed pmid="8496537"/></Publication><Publication><Pubmed pmid="8496869"/></Publication><Publication><Pubmed pmid="8511983"/></Publication><Publication><Pubmed pmid="8546548"/></Publication><Publication><Pubmed pmid="8551169"/></Publication><Publication><Pubmed pmid="8595803"/></Publication><Publication><Pubmed pmid="8595804"/></Publication><Publication><Pubmed pmid="8598840"/></Publication><Publication><Pubmed pmid="8602715"/></Publication><Publication><Pubmed pmid="8604632"/></Publication><Publication><Pubmed pmid="8604956"/></Publication><Publication><Pubmed pmid="8605666"/></Publication><Publication><Pubmed pmid="8605667"/></Publication><Publication><Pubmed pmid="8608620"/></Publication><Publication><Pubmed pmid="8611279"/></Publication><Publication><Pubmed pmid="8614751"/></Publication><Publication><Pubmed pmid="8615332"/></Publication><Publication><Pubmed pmid="8618665"/></Publication><Publication><Pubmed pmid="8621991"/></Publication><Publication><Pubmed pmid="8622246"/></Publication><Publication><Pubmed pmid="8622248"/></Publication><Publication><Pubmed pmid="8622253"/></Publication><Publication><Pubmed pmid="8630116"/></Publication><Publication><Pubmed pmid="8630210"/></Publication><Publication><Pubmed pmid="11943044"/></Publication><Publication><Pubmed pmid="8633618"/></Publication><Publication><Pubmed pmid="8640988"/></Publication><Publication><Pubmed pmid="8640998"/></Publication><Publication><Pubmed pmid="8651087"/></Publication><Publication><Pubmed pmid="8656227"/></Publication><Publication><Pubmed pmid="8656228"/></Publication><Publication><Pubmed pmid="8701860"/></Publication><Publication><Pubmed pmid="8702085"/></Publication><Publication><Pubmed pmid="8709403"/></Publication><Publication><Pubmed pmid="8712127"/></Publication><Publication><Pubmed pmid="8721656"/></Publication><Publication><Pubmed pmid="8729094"/></Publication><Publication><Pubmed pmid="8730132"/></Publication><Publication><Pubmed pmid="8780363"/></Publication><Publication><Pubmed pmid="8783299"/></Publication><Publication><Pubmed pmid="8790072"/></Publication><Publication><Pubmed pmid="8814971"/></Publication><Publication><Pubmed pmid="8823682"/></Publication><Publication><Pubmed pmid="8831910"/></Publication><Publication><Pubmed pmid="8831931"/></Publication><Publication><Pubmed pmid="8834926"/></Publication><Publication><Pubmed pmid="8841325"/></Publication><Publication><Pubmed pmid="8843183"/></Publication><Publication><Pubmed pmid="8848993"/></Publication><Publication><Pubmed pmid="8849757"/></Publication><Publication><Pubmed pmid="8849758"/></Publication><Publication><Pubmed pmid="8857921"/></Publication><Publication><Pubmed pmid="8870338"/></Publication><Publication><Pubmed pmid="8879836"/></Publication><Publication><Pubmed pmid="8882042"/></Publication><Publication><Pubmed pmid="8883494"/></Publication><Publication><Pubmed pmid="8906082"/></Publication><Publication><Pubmed pmid="8917269"/></Publication><Publication><Pubmed pmid="8941112"/></Publication><Publication><Pubmed pmid="8968013"/></Publication><Publication><Pubmed pmid="8977456"/></Publication><Publication><Pubmed pmid="9001370"/></Publication><Publication><Pubmed pmid="9032046"/></Publication><Publication><Pubmed pmid="9033509"/></Publication><Publication><Pubmed pmid="9034401"/></Publication><Publication><Pubmed pmid="9034402"/></Publication><Publication><Pubmed pmid="9048116"/></Publication><Publication><Pubmed pmid="9048514"/></Publication><Publication><Pubmed pmid="9054738"/></Publication><Publication><Pubmed pmid="9095456"/></Publication><Publication><Pubmed pmid="9101518"/></Publication><Publication><Pubmed pmid="9106797"/></Publication><Publication><Pubmed pmid="9125257"/></Publication><Publication><Pubmed pmid="9134875"/></Publication><Publication><Pubmed pmid="9158553"/></Publication><Publication><Pubmed pmid="9167921"/></Publication><Publication><Pubmed pmid="9183225"/></Publication><Publication><Pubmed pmid="9200004"/></Publication><Publication><Pubmed pmid="9201664"/></Publication><Publication><Pubmed pmid="9211012"/></Publication><Publication><Pubmed pmid="9216550"/></Publication><Publication><Pubmed pmid="9217668"/></Publication><Publication><Pubmed pmid="9228134"/></Publication><Publication><Pubmed pmid="9229203"/></Publication><Publication><Pubmed pmid="9229205"/></Publication><Publication><Pubmed pmid="9236415"/></Publication><Publication><Pubmed pmid="9236450"/></Publication><Publication><Pubmed pmid="9238407"/></Publication><Publication><Pubmed pmid="9242971"/></Publication><Publication><Pubmed pmid="9248817"/></Publication><Publication><Pubmed pmid="9253101"/></Publication><Publication><Pubmed pmid="9262494"/></Publication><Publication><Pubmed pmid="9264491"/></Publication><Publication><Pubmed pmid="9264498"/></Publication><Publication><Pubmed pmid="9283785"/></Publication><Publication><Pubmed pmid="9286929"/></Publication><Publication><Pubmed pmid="9298050"/></Publication><Publication><Pubmed pmid="9313755"/></Publication><Publication><Pubmed pmid="9322570"/></Publication><Publication><Pubmed pmid="9322573"/></Publication><Publication><Pubmed pmid="9323074"/></Publication><Publication><Pubmed pmid="9351745"/></Publication><Publication><Pubmed pmid="9354744"/></Publication><Publication><Pubmed pmid="9360850"/></Publication><Publication><Pubmed pmid="9369249"/></Publication><Publication><Pubmed pmid="9369250"/></Publication><Publication><Pubmed pmid="9375942"/></Publication><Publication><Pubmed pmid="9402810"/></Publication><Publication><Pubmed pmid="9404469"/></Publication><Publication><Pubmed pmid="9409336"/></Publication><Publication><Pubmed pmid="9417007"/></Publication><Publication><Pubmed pmid="9431486"/></Publication><Publication><Pubmed pmid="9467429"/></Publication><Publication><Pubmed pmid="9485998"/></Publication><Publication><Pubmed pmid="9493915"/></Publication><Publication><Pubmed pmid="9518396"/></Publication><Publication><Pubmed pmid="9537620"/></Publication><Publication><Pubmed pmid="9546917"/></Publication><Publication><Pubmed pmid="9550513"/></Publication><Publication><Pubmed pmid="9550515"/></Publication><Publication><Pubmed pmid="9555748"/></Publication><Publication><Pubmed pmid="9564991"/></Publication><Publication><Pubmed pmid="9569599"/></Publication><Publication><Pubmed pmid="9575602"/></Publication><Publication><Pubmed pmid="9588653"/></Publication><Publication><Pubmed pmid="9597054"/></Publication><Publication><Pubmed pmid="9603122"/></Publication><Publication><Pubmed pmid="9603529"/></Publication><Publication><Pubmed pmid="9603539"/></Publication><Publication><Pubmed pmid="9625046"/></Publication><Publication><Pubmed pmid="9627016"/></Publication><Publication><Pubmed pmid="9663229"/></Publication><Publication><Pubmed pmid="9696729"/></Publication><Publication><Pubmed pmid="9704680"/></Publication><Publication><Pubmed pmid="9707189"/></Publication><Publication><Pubmed pmid="9717884"/></Publication><Publication><Pubmed pmid="9719057"/></Publication><Publication><Pubmed pmid="9733466"/></Publication><Publication><Pubmed pmid="9737512"/></Publication><Publication><Pubmed pmid="9737513"/></Publication><Publication><Pubmed pmid="9744977"/></Publication><Publication><Pubmed pmid="9759683"/></Publication><Publication><Pubmed pmid="9762744"/></Publication><Publication><Pubmed pmid="9773714"/></Publication><Publication><Pubmed pmid="9778229"/></Publication><Publication><Pubmed pmid="9803957"/></Publication><Publication><Pubmed pmid="9809895"/></Publication><Publication><Pubmed pmid="9809962"/></Publication><Publication><Pubmed pmid="9812089"/></Publication><Publication><Pubmed pmid="9812913"/></Publication><Publication><Pubmed pmid="9820460"/></Publication><Publication><Pubmed pmid="9820465"/></Publication><Publication><Pubmed pmid="9820468"/></Publication><Publication><Pubmed pmid="9822437"/></Publication><Publication><Pubmed pmid="9851760"/></Publication><Publication><Pubmed pmid="9858111"/></Publication><Publication><Pubmed pmid="9860378"/></Publication><Publication><Pubmed pmid="9867756"/></Publication><Publication><Pubmed pmid="9884395"/></Publication><Publication><Pubmed pmid="9920011"/></Publication><Publication><Pubmed pmid="9921953"/></Publication><Publication><Pubmed pmid="9927364"/></Publication><Publication><Pubmed pmid="10023892"/></Publication><Publication><Pubmed pmid="10024624"/></Publication><Publication><Pubmed pmid="10025925"/></Publication><Publication><Pubmed pmid="10030399"/></Publication><Publication><Pubmed pmid="10100690"/></Publication><Publication><Pubmed pmid="10163450"/></Publication><Publication><Pubmed pmid="10190375"/></Publication><Publication><Pubmed pmid="10190406"/></Publication><Publication><Pubmed pmid="10191978"/></Publication><Publication><Pubmed pmid="10191979"/></Publication><Publication><Pubmed pmid="10195947"/></Publication><Publication><Pubmed pmid="10197575"/></Publication><Publication><Pubmed pmid="10199879"/></Publication><Publication><Pubmed pmid="10203375"/></Publication><Publication><Pubmed pmid="10210704"/></Publication><Publication><Pubmed pmid="10220640"/></Publication><Publication><Pubmed pmid="10226089"/></Publication><Publication><Pubmed pmid="10230743"/></Publication><Publication><Pubmed pmid="10320382"/></Publication><Publication><Pubmed pmid="10329332"/></Publication><Publication><Pubmed pmid="10335684"/></Publication><Publication><Pubmed pmid="10335688"/></Publication><Publication><Pubmed pmid="10340839"/></Publication><Publication><Pubmed pmid="10362198"/></Publication><Publication><Pubmed pmid="10362225"/></Publication><Publication><Pubmed pmid="10367922"/></Publication><Publication><Pubmed pmid="10368520"/></Publication><Publication><Pubmed pmid="10371227"/></Publication><Publication><Pubmed pmid="10387935"/></Publication><Publication><Pubmed pmid="10388480"/></Publication><Publication><Pubmed pmid="10391820"/></Publication><Publication><Pubmed pmid="10400256"/></Publication><Publication><Pubmed pmid="10414557"/></Publication><Publication><Pubmed pmid="10421594"/></Publication><Publication><Pubmed pmid="10448783"/></Publication><Publication><Pubmed pmid="10450862"/></Publication><Publication><Pubmed pmid="10465319"/></Publication><Publication><Pubmed pmid="10467214"/></Publication><Publication><Pubmed pmid="10471455"/></Publication><Publication><Pubmed pmid="10475888"/></Publication><Publication><Pubmed pmid="10489380"/></Publication><Publication><Pubmed pmid="10489997"/></Publication><Publication><Pubmed pmid="10508208"/></Publication><Publication><Pubmed pmid="10520821"/></Publication><Publication><Pubmed pmid="10526697"/></Publication><Publication><Pubmed pmid="10527298"/></Publication><Publication><Pubmed pmid="10539821"/></Publication><Publication><Pubmed pmid="10553388"/></Publication><Publication><Pubmed pmid="10562260"/></Publication><Publication><Pubmed pmid="10568672"/></Publication><Publication><Pubmed pmid="10569646"/></Publication><Publication><Pubmed pmid="10577100"/></Publication><Publication><Pubmed pmid="10577585"/></Publication><Publication><Pubmed pmid="10588081"/></Publication><Publication><Pubmed pmid="10594797"/></Publication><Publication><Pubmed pmid="10604919"/></Publication><Publication><Pubmed pmid="10634338"/></Publication><Publication><Pubmed pmid="10636448"/></Publication><Publication><Pubmed pmid="10645922"/></Publication><Publication><Pubmed pmid="10648042"/></Publication><Publication><Pubmed pmid="10648266"/></Publication><Publication><Pubmed pmid="10650300"/></Publication><Publication><Pubmed pmid="10657570"/></Publication><Publication><Pubmed pmid="10669660"/></Publication><Publication><Pubmed pmid="10673173"/></Publication><Publication><Pubmed pmid="10678282"/></Publication><Publication><Pubmed pmid="10686532"/></Publication><Publication><Pubmed pmid="10689255"/></Publication><Publication><Pubmed pmid="10706323"/></Publication><Publication><Pubmed pmid="10712408"/></Publication><Publication><Pubmed pmid="10713509"/></Publication><Publication><Pubmed pmid="10719763"/></Publication><Publication><Pubmed pmid="10723112"/></Publication><Publication><Pubmed pmid="10736296"/></Publication><Publication><Pubmed pmid="10737693"/></Publication><Publication><Pubmed pmid="10740155"/></Publication><Publication><Pubmed pmid="10752796"/></Publication><Publication><Pubmed pmid="10754017"/></Publication><Publication><Pubmed pmid="10760631"/></Publication><Publication><Pubmed pmid="10780863"/></Publication><Publication><Pubmed pmid="10782833"/></Publication><Publication><Pubmed pmid="10783221"/></Publication><Publication><Pubmed pmid="10784242"/></Publication><Publication><Pubmed pmid="10790356"/></Publication><Publication><Pubmed pmid="10799384"/></Publication><Publication><Pubmed pmid="10801999"/></Publication><Publication><Pubmed pmid="10806290"/></Publication><Publication><Pubmed pmid="10807749"/></Publication><Publication><Pubmed pmid="10814713"/></Publication><Publication><Pubmed pmid="10818059"/></Publication><Publication><Pubmed pmid="10834428"/></Publication><Publication><Pubmed pmid="10844714"/></Publication><Publication><Pubmed pmid="10867777"/></Publication><Publication><Pubmed pmid="10872616"/></Publication><Publication><Pubmed pmid="10884295"/></Publication><Publication><Pubmed pmid="10886491"/></Publication><Publication><Pubmed pmid="10922439"/></Publication><Publication><Pubmed pmid="10936471"/></Publication><Publication><Pubmed pmid="10938003"/></Publication><Publication><Pubmed pmid="10953260"/></Publication><Publication><Pubmed pmid="10955386"/></Publication><Publication><Pubmed pmid="10980814"/></Publication><Publication><Pubmed pmid="10981154"/></Publication><Publication><Pubmed pmid="10984105"/></Publication><Publication><Pubmed pmid="11015340"/></Publication><Publication><Pubmed pmid="11029370"/></Publication><Publication><Pubmed pmid="11033593"/></Publication><Publication><Pubmed pmid="11040222"/></Publication><Publication><Pubmed pmid="11040241"/></Publication><Publication><Pubmed pmid="11050787"/></Publication><Publication><Pubmed pmid="11071176"/></Publication><Publication><Pubmed pmid="11080135"/></Publication><Publication><Pubmed pmid="11093294"/></Publication><Publication><Pubmed pmid="11118026"/></Publication><Publication><Pubmed pmid="11118392"/></Publication><Publication><Pubmed pmid="11119396"/></Publication><Publication><Pubmed pmid="11120700"/></Publication><Publication><Pubmed pmid="11127216"/></Publication><Publication><Pubmed pmid="11137104"/></Publication><Publication><Pubmed pmid="11152833"/></Publication><Publication><Pubmed pmid="11158071"/></Publication><Publication><Pubmed pmid="11159144"/></Publication><Publication><Pubmed pmid="11165466"/></Publication><Publication><Pubmed pmid="11237940"/></Publication><Publication><Pubmed pmid="11237943"/></Publication><Publication><Pubmed pmid="11238268"/></Publication><Publication><Pubmed pmid="11255447"/></Publication><Publication><Pubmed pmid="11257080"/></Publication><Publication><Pubmed pmid="11257253"/></Publication><Publication><Pubmed pmid="11257261"/></Publication><Publication><Pubmed pmid="11271691"/></Publication><Publication><Pubmed pmid="11273848"/></Publication><Publication><Pubmed pmid="11289690"/></Publication><Publication><Pubmed pmid="11295957"/></Publication><Publication><Pubmed pmid="11295996"/></Publication><Publication><Pubmed pmid="11305971"/></Publication><Publication><Pubmed pmid="11356398"/></Publication><Publication><Pubmed pmid="11385074"/></Publication><Publication><Pubmed pmid="11386895"/></Publication><Publication><Pubmed pmid="11401933"/></Publication><Publication><Pubmed pmid="11411265"/></Publication><Publication><Pubmed pmid="11416288"/></Publication><Publication><Pubmed pmid="11416289"/></Publication><Publication><Pubmed pmid="11416310"/></Publication><Publication><Pubmed pmid="11416387"/></Publication><Publication><Pubmed pmid="11416464"/></Publication><Publication><Pubmed pmid="11416564"/></Publication><Publication><Pubmed pmid="11423496"/></Publication><Publication><Pubmed pmid="11447076"/></Publication><Publication><Pubmed pmid="11448281"/></Publication><Publication><Pubmed pmid="11454842"/></Publication><Publication><Pubmed pmid="11458282"/></Publication><Publication><Pubmed pmid="11468215"/></Publication><Publication><Pubmed pmid="11470724"/></Publication><Publication><Pubmed pmid="11473077"/></Publication><Publication><Pubmed pmid="11485278"/></Publication><Publication><Pubmed pmid="11500189"/></Publication><Publication><Pubmed pmid="11520482"/></Publication><Publication><Pubmed pmid="11527137"/></Publication><Publication><Pubmed pmid="11560851"/></Publication><Publication><Pubmed pmid="11571351"/></Publication><Publication><Pubmed pmid="11576815"/></Publication><Publication><Pubmed pmid="11587973"/></Publication><Publication><Pubmed pmid="11593027"/></Publication><Publication><Pubmed pmid="11593349"/></Publication><Publication><Pubmed pmid="11606150"/></Publication><Publication><Pubmed pmid="11683533"/></Publication><Publication><Pubmed pmid="11692019"/></Publication><Publication><Pubmed pmid="11700246"/></Publication><Publication><Pubmed pmid="11719305"/></Publication><Publication><Pubmed pmid="11728544"/></Publication><Publication><Pubmed pmid="11730822"/></Publication><Publication><Pubmed pmid="11739880"/></Publication><Publication><Pubmed pmid="11756058"/></Publication><Publication><Pubmed pmid="11760840"/></Publication><Publication><Pubmed pmid="11772875"/></Publication><Publication><Pubmed pmid="11779915"/></Publication><Publication><Pubmed pmid="11794147"/></Publication><Publication><Pubmed pmid="11823590"/></Publication><Publication><Pubmed pmid="11823591"/></Publication><Publication><Pubmed pmid="11824954"/></Publication><Publication><Pubmed pmid="11827493"/></Publication><Publication><Pubmed pmid="11842948"/></Publication><Publication><Pubmed pmid="11844848"/></Publication><Publication><Pubmed pmid="11863248"/></Publication><Publication><Pubmed pmid="11866648"/></Publication><Publication><Pubmed pmid="11872688"/></Publication><Publication><Pubmed pmid="11872966"/></Publication><Publication><Pubmed pmid="11872968"/></Publication><Publication><Pubmed pmid="11872970"/></Publication><Publication><Pubmed pmid="11897450"/></Publication><Publication><Pubmed pmid="11897646"/></Publication><Publication><Pubmed pmid="11935035"/></Publication><Publication><Pubmed pmid="11953971"/></Publication><Publication><Pubmed pmid="11964437"/></Publication><Publication><Pubmed pmid="11974672"/></Publication><Publication><Pubmed pmid="11988460"/></Publication><Publication><Pubmed pmid="11996610"/></Publication><Publication><Pubmed pmid="12006394"/></Publication><Publication><Pubmed pmid="12006401"/></Publication><Publication><Pubmed pmid="12031742"/></Publication><Publication><Pubmed pmid="12032102"/></Publication><Publication><Pubmed pmid="12032104"/></Publication><Publication><Pubmed pmid="12042430"/></Publication><Publication><Pubmed pmid="12075249"/></Publication><Publication><Pubmed pmid="12081842"/></Publication><Publication><Pubmed pmid="12105290"/></Publication><Publication><Pubmed pmid="12115226"/></Publication><Publication><Pubmed pmid="12119250"/></Publication><Publication><Pubmed pmid="12127613"/></Publication><Publication><Pubmed pmid="12145012"/></Publication><Publication><Pubmed pmid="12145227"/></Publication><Publication><Pubmed pmid="12151467"/></Publication><Publication><Pubmed pmid="12196085"/></Publication><Publication><Pubmed pmid="12202958"/></Publication><Publication><Pubmed pmid="12204489"/></Publication><Publication><Pubmed pmid="12208790"/></Publication><Publication><Pubmed pmid="12211443"/></Publication><Publication><Pubmed pmid="12215132"/></Publication><Publication><Pubmed pmid="12221247"/></Publication><Publication><Pubmed pmid="12239256"/></Publication><Publication><Pubmed pmid="12351489"/></Publication><Publication><Pubmed pmid="12355400"/></Publication><Publication><Pubmed pmid="12356380"/></Publication><Publication><Pubmed pmid="12360172"/></Publication><Publication><Pubmed pmid="12372572"/></Publication><Publication><Pubmed pmid="12377746"/></Publication><Publication><Pubmed pmid="12378368"/></Publication><Publication><Pubmed pmid="12379169"/></Publication><Publication><Pubmed pmid="12379170"/></Publication><Publication><Pubmed pmid="12383578"/></Publication><Publication><Pubmed pmid="12392829"/></Publication><Publication><Pubmed pmid="12403660"/></Publication><Publication><Pubmed pmid="12409541"/></Publication><Publication><Pubmed pmid="12411456"/></Publication><Publication><Pubmed pmid="12427878"/></Publication><Publication><Pubmed pmid="12428097"/></Publication><Publication><Pubmed pmid="12446258"/></Publication><Publication><Pubmed pmid="12450906"/></Publication><Publication><Pubmed pmid="12460521"/></Publication><Publication><Pubmed pmid="12460872"/></Publication><Publication><Pubmed pmid="12473553"/></Publication><Publication><Pubmed pmid="12480036"/></Publication><Publication><Pubmed pmid="12482550"/></Publication><Publication><Pubmed pmid="12488481"/></Publication><Publication><Pubmed pmid="12511750"/></Publication><Publication><Pubmed pmid="12513039"/></Publication><Publication><Pubmed pmid="12517363"/></Publication><Publication><Pubmed pmid="12540314"/></Publication><Publication><Pubmed pmid="12540415"/></Publication><Publication><Pubmed pmid="12548671"/></Publication><Publication><Pubmed pmid="12551870"/></Publication><Publication><Pubmed pmid="12574549"/></Publication><Publication><Pubmed pmid="12586275"/></Publication><Publication><Pubmed pmid="12587008"/></Publication><Publication><Pubmed pmid="12590413"/></Publication><Publication><Pubmed pmid="12595633"/></Publication><Publication><Pubmed pmid="12615693"/></Publication><Publication><Pubmed pmid="12618960"/></Publication><Publication><Pubmed pmid="12622536"/></Publication><Publication><Pubmed pmid="12622955"/></Publication><Publication><Pubmed pmid="12623825"/></Publication><Publication><Pubmed pmid="12623860"/></Publication><Publication><Pubmed pmid="12623868"/></Publication><Publication><Pubmed pmid="12633186"/></Publication><Publication><Pubmed pmid="12641483"/></Publication><Publication><Pubmed pmid="12654604"/></Publication><Publication><Pubmed pmid="12654605"/></Publication><Publication><Pubmed pmid="12663278"/></Publication><Publication><Pubmed pmid="12672188"/></Publication><Publication><Pubmed pmid="12682318"/></Publication><Publication><Pubmed pmid="12697743"/></Publication><Publication><Pubmed pmid="12698067"/></Publication><Publication><Pubmed pmid="12711495"/></Publication><Publication><Pubmed pmid="12714150"/></Publication><Publication><Pubmed pmid="12739029"/></Publication><Publication><Pubmed pmid="12742802"/></Publication><Publication><Pubmed pmid="12760179"/></Publication><Publication><Pubmed pmid="12765971"/></Publication><Publication><Pubmed pmid="12771006"/></Publication><Publication><Pubmed pmid="12779301"/></Publication><Publication><Pubmed pmid="12788901"/></Publication><Publication><Pubmed pmid="12792620"/></Publication><Publication><Pubmed pmid="12799124"/></Publication><Publication><Pubmed pmid="12821537"/></Publication><Publication><Pubmed pmid="12821969"/></Publication><Publication><Pubmed pmid="12847072"/></Publication><Publication><Pubmed pmid="12849297"/></Publication><Publication><Pubmed pmid="12874190"/></Publication><Publication><Pubmed pmid="12875746"/></Publication><Publication><Pubmed pmid="12877910"/></Publication><Publication><Pubmed pmid="12882936"/></Publication><Publication><Pubmed pmid="12883073"/></Publication><Publication><Pubmed pmid="12912813"/></Publication><Publication><Pubmed pmid="12919235"/></Publication><Publication><Pubmed pmid="12924350"/></Publication><Publication><Pubmed pmid="12928465"/></Publication><Publication><Pubmed pmid="12930631"/></Publication><Publication><Pubmed pmid="12941677"/></Publication><Publication><Pubmed pmid="12963567"/></Publication><Publication><Pubmed pmid="12963571"/></Publication><Publication><Pubmed pmid="12966033"/></Publication><Publication><Pubmed pmid="12971590"/></Publication><Publication><Pubmed pmid="12975387"/></Publication><Publication><Pubmed pmid="13214371"/></Publication><Publication><Pubmed pmid="13378647"/></Publication><Publication><Pubmed pmid="13411327"/></Publication><Publication><Pubmed pmid="13493903"/></Publication><Publication><Pubmed pmid="13606677"/></Publication><Publication><Pubmed pmid="13661764"/></Publication><Publication><Pubmed pmid="13678771"/></Publication><Publication><Pubmed pmid="13720286"/></Publication><Publication><Pubmed pmid="13751193"/></Publication><Publication><Pubmed pmid="13814552"/></Publication><Publication><Pubmed pmid="13814553"/></Publication><Publication><Pubmed pmid="13881407"/></Publication><Publication><Pubmed pmid="13884013"/></Publication><Publication><Pubmed pmid="13884014"/></Publication><Publication><Pubmed pmid="13887664"/></Publication><Publication><Pubmed pmid="13958288"/></Publication><Publication><Pubmed pmid="13981873"/></Publication><Publication><Pubmed pmid="14025560"/></Publication><Publication><Pubmed pmid="14025561"/></Publication><Publication><Pubmed pmid="14025562"/></Publication><Publication><Pubmed pmid="14025563"/></Publication><Publication><Pubmed pmid="14025564"/></Publication><Publication><Pubmed pmid="14057660"/></Publication><Publication><Pubmed pmid="14150877"/></Publication><Publication><Pubmed pmid="14214489"/></Publication><Publication><Pubmed pmid="14233810"/></Publication><Publication><Pubmed pmid="14306410"/></Publication><Publication><Pubmed pmid="14319212"/></Publication><Publication><Pubmed pmid="14325143"/></Publication><Publication><Pubmed pmid="14453051"/></Publication><Publication><Pubmed pmid="14453635"/></Publication><Publication><Pubmed pmid="14469319"/></Publication><Publication><Pubmed pmid="14504251"/></Publication><Publication><Pubmed pmid="14517148"/></Publication><Publication><Pubmed pmid="14559957"/></Publication><Publication><Pubmed pmid="14563498"/></Publication><Publication><Pubmed pmid="14566097"/></Publication><Publication><Pubmed pmid="14568852"/></Publication><Publication><Pubmed pmid="14576979"/></Publication><Publication><Pubmed pmid="14597642"/></Publication><Publication><Pubmed pmid="14600184"/></Publication><Publication><Pubmed pmid="14608050"/></Publication><Publication><Pubmed pmid="14608052"/></Publication><Publication><Pubmed pmid="14615618"/></Publication><Publication><Pubmed pmid="14627797"/></Publication><Publication><Pubmed pmid="14635163"/></Publication><Publication><Pubmed pmid="14635166"/></Publication><Publication><Pubmed pmid="14635169"/></Publication><Publication><Pubmed pmid="14635173"/></Publication><Publication><Pubmed pmid="14663042"/></Publication><Publication><Pubmed pmid="14687347"/></Publication><Publication><Pubmed pmid="14694215"/></Publication><Publication><Pubmed pmid="14698976"/></Publication><Publication><Pubmed pmid="14716734"/></Publication><Publication><Pubmed pmid="14724717"/></Publication><Publication><Pubmed pmid="14726556"/></Publication><Publication><Pubmed pmid="14728630"/></Publication><Publication><Pubmed pmid="14730480"/></Publication><Publication><Pubmed pmid="14747241"/></Publication><Publication><Pubmed pmid="14760568"/></Publication><Publication><Pubmed pmid="14764933"/></Publication><Publication><Pubmed pmid="14769680"/></Publication><Publication><Pubmed pmid="14769683"/></Publication><Publication><Pubmed pmid="14770200"/></Publication><Publication><Pubmed pmid="14819398"/></Publication><Publication><Pubmed pmid="14916472"/></Publication><Publication><Pubmed pmid="14960742"/></Publication><Publication><Pubmed pmid="14963283"/></Publication><Publication><Pubmed pmid="14969400"/></Publication><Publication><Pubmed pmid="14969614"/></Publication><Publication><Pubmed pmid="14970063"/></Publication><Publication><Pubmed pmid="14975070"/></Publication><Publication><Pubmed pmid="14975071"/></Publication><Publication><Pubmed pmid="14975083"/></Publication><Publication><Pubmed pmid="14975097"/></Publication><Publication><Pubmed pmid="14975098"/></Publication><Publication><Pubmed pmid="14975101"/></Publication><Publication><Pubmed pmid="14975102"/></Publication><Publication><Pubmed pmid="14975113"/></Publication><Publication><Pubmed pmid="14975115"/></Publication><Publication><Pubmed pmid="14975124"/></Publication><Publication><Pubmed pmid="14975144"/></Publication><Publication><Pubmed pmid="14975148"/></Publication><Publication><Pubmed pmid="14975163"/></Publication><Publication><Pubmed pmid="14975164"/></Publication><Publication><Pubmed pmid="14975165"/></Publication><Publication><Pubmed pmid="14975168"/></Publication><Publication><Pubmed pmid="14975174"/></Publication><Publication><Pubmed pmid="14980992"/></Publication><Publication><Pubmed pmid="14988289"/></Publication><Publication><Pubmed pmid="14993133"/></Publication><Publication><Pubmed pmid="15003802"/></Publication><Publication><Pubmed pmid="15003803"/></Publication><Publication><Pubmed pmid="15003963"/></Publication><Publication><Pubmed pmid="15005841"/></Publication><Publication><Pubmed pmid="15006822"/></Publication><Publication><Pubmed pmid="15007028"/></Publication><Publication><Pubmed pmid="15019547"/></Publication><Publication><Pubmed pmid="15019874"/></Publication><Publication><Pubmed pmid="15023709"/></Publication><Publication><Pubmed pmid="15031305"/></Publication><Publication><Pubmed pmid="15039133"/></Publication><Publication><Pubmed pmid="15040829"/></Publication><Publication><Pubmed pmid="15064104"/></Publication><Publication><Pubmed pmid="15068501"/></Publication><Publication><Pubmed pmid="15107310"/></Publication><Publication><Pubmed pmid="15111512"/></Publication><Publication><Pubmed pmid="15118167"/></Publication><Publication><Pubmed pmid="15122742"/></Publication><Publication><Pubmed pmid="15123572"/></Publication><Publication><Pubmed pmid="15128607"/></Publication><Publication><Pubmed pmid="15138242"/></Publication><Publication><Pubmed pmid="15141042"/></Publication><Publication><Pubmed pmid="15143299"/></Publication><Publication><Pubmed pmid="15148273"/></Publication><Publication><Pubmed pmid="15155954"/></Publication><Publication><Pubmed pmid="15161798"/></Publication><Publication><Pubmed pmid="15164311"/></Publication><Publication><Pubmed pmid="15167201"/></Publication><Publication><Pubmed pmid="15173025"/></Publication><Publication><Pubmed pmid="15173150"/></Publication><Publication><Pubmed pmid="15179102"/></Publication><Publication><Pubmed pmid="15197153"/></Publication><Publication><Pubmed pmid="15199036"/></Publication><Publication><Pubmed pmid="15210652"/></Publication><Publication><Pubmed pmid="15211606"/></Publication><Publication><Pubmed pmid="15215787"/></Publication><Publication><Pubmed pmid="15218158"/></Publication><Publication><Pubmed pmid="15219502"/></Publication><Publication><Pubmed pmid="15229305"/></Publication><Publication><Pubmed pmid="15234428"/></Publication><Publication><Pubmed pmid="15245336"/></Publication><Publication><Pubmed pmid="15249547"/></Publication><Publication><Pubmed pmid="15249796"/></Publication><Publication><Pubmed pmid="15256397"/></Publication><Publication><Pubmed pmid="15258198"/></Publication><Publication><Pubmed pmid="15262291"/></Publication><Publication><Pubmed pmid="15262834"/></Publication><Publication><Pubmed pmid="15262842"/></Publication><Publication><Pubmed pmid="15276113"/></Publication><Publication><Pubmed pmid="15292370"/></Publication><Publication><Pubmed pmid="15294874"/></Publication><Publication><Pubmed pmid="15313941"/></Publication><Publication><Pubmed pmid="15326239"/></Publication><Publication><Pubmed pmid="15331309"/></Publication><Publication><Pubmed pmid="15331311"/></Publication><Publication><Pubmed pmid="15331317"/></Publication><Publication><Pubmed pmid="15334462"/></Publication><Publication><Pubmed pmid="15339995"/></Publication><Publication><Pubmed pmid="15341685"/></Publication><Publication><Pubmed pmid="15342170"/></Publication><Publication><Pubmed pmid="15342688"/></Publication><Publication><Pubmed pmid="15354158"/></Publication><Publication><Pubmed pmid="15359070"/></Publication><Publication><Pubmed pmid="15367573"/></Publication><Publication><Pubmed pmid="15371099"/></Publication><Publication><Pubmed pmid="15383406"/></Publication><Publication><Pubmed pmid="15388521"/></Publication><Publication><Pubmed pmid="15451778"/></Publication><Publication><Pubmed pmid="15456630"/></Publication><Publication><Pubmed pmid="15464673"/></Publication><Publication><Pubmed pmid="15464686"/></Publication><Publication><Pubmed pmid="15472183"/></Publication><Publication><Pubmed pmid="15485750"/></Publication><Publication><Pubmed pmid="15495890"/></Publication><Publication><Pubmed pmid="15496174"/></Publication><Publication><Pubmed pmid="15528461"/></Publication><Publication><Pubmed pmid="15534241"/></Publication><Publication><Pubmed pmid="15545512"/></Publication><Publication><Pubmed pmid="15562019"/></Publication><Publication><Pubmed pmid="15562125"/></Publication><Publication><Pubmed pmid="15562129"/></Publication><Publication><Pubmed pmid="15569842"/></Publication><Publication><Pubmed pmid="15569852"/></Publication><Publication><Pubmed pmid="15597108"/></Publication><Publication><Pubmed pmid="15610229"/></Publication><Publication><Pubmed pmid="15611369"/></Publication><Publication><Pubmed pmid="15613939"/></Publication><Publication><Pubmed pmid="15619681"/></Publication><Publication><Pubmed pmid="15635079"/></Publication><Publication><Pubmed pmid="15642856"/></Publication><Publication><Pubmed pmid="15653178"/></Publication><Publication><Pubmed pmid="15662040"/></Publication><Publication><Pubmed pmid="15673620"/></Publication><Publication><Pubmed pmid="15721024"/></Publication><Publication><Pubmed pmid="15723980"/></Publication><Publication><Pubmed pmid="15726295"/></Publication><Publication><Pubmed pmid="15642771"/></Publication><Publication><Pubmed pmid="15734611"/></Publication><Publication><Pubmed pmid="15735069"/></Publication><Publication><Pubmed pmid="15738353"/></Publication><Publication><Pubmed pmid="15761175"/></Publication><Publication><Pubmed pmid="15767617"/></Publication><Publication><Pubmed pmid="15769979"/></Publication><Publication><Pubmed pmid="15769990"/></Publication><Publication><Pubmed pmid="15775729"/></Publication><Publication><Pubmed pmid="15781015"/></Publication><Publication><Pubmed pmid="15798116"/></Publication><Publication><Pubmed pmid="15805549"/></Publication><Publication><Pubmed pmid="15818710"/></Publication><Publication><Pubmed pmid="15829237"/></Publication><Publication><Pubmed pmid="15851319"/></Publication><Publication><Pubmed pmid="15851636"/></Publication><Publication><Pubmed pmid="15861008"/></Publication><Publication><Pubmed pmid="15867473"/></Publication><Publication><Pubmed pmid="15882545"/></Publication><Publication><Pubmed pmid="15882548"/></Publication><Publication><Pubmed pmid="15956011"/></Publication><Publication><Pubmed pmid="15956133"/></Publication><Publication><Pubmed pmid="15956806"/></Publication><Publication><Pubmed pmid="15965659"/></Publication><Publication><Pubmed pmid="15972604"/></Publication><Publication><Pubmed pmid="15974883"/></Publication><Publication><Pubmed pmid="15975170"/></Publication><Publication><Pubmed pmid="15982814"/></Publication><Publication><Pubmed pmid="15998672"/></Publication><Publication><Pubmed pmid="16002816"/></Publication><Publication><Pubmed pmid="16005459"/></Publication><Publication><Pubmed pmid="16014638"/></Publication><Publication><Pubmed pmid="16018848"/></Publication><Publication><Pubmed pmid="16046653"/></Publication><Publication><Pubmed pmid="16076834"/></Publication><Publication><Pubmed pmid="16087792"/></Publication><Publication><Pubmed pmid="16107567"/></Publication><Publication><Pubmed pmid="16116069"/></Publication><Publication><Pubmed pmid="16129794"/></Publication><Publication><Pubmed pmid="16139531"/></Publication><Publication><Pubmed pmid="16144952"/></Publication><Publication><Pubmed pmid="16145676"/></Publication><Publication><Pubmed pmid="16157770"/></Publication><Publication><Pubmed pmid="16157784"/></Publication><Publication><Pubmed pmid="16159602"/></Publication><Publication><Pubmed pmid="16159603"/></Publication><Publication><Pubmed pmid="16172282"/></Publication><Publication><Pubmed pmid="16186276"/></Publication><Publication><Pubmed pmid="16197286"/></Publication><Publication><Pubmed pmid="16198088"/></Publication><Publication><Pubmed pmid="16204159"/></Publication><Publication><Pubmed pmid="16204425"/></Publication><Publication><Pubmed pmid="16204426"/></Publication><Publication><Pubmed pmid="16219884"/></Publication><Publication><Pubmed pmid="16223549"/></Publication><Publication><Pubmed pmid="16228142"/></Publication><Publication><Pubmed pmid="16249452"/></Publication><Publication><Pubmed pmid="16253598"/></Publication><Publication><Pubmed pmid="16253630"/></Publication><Publication><Pubmed pmid="16256756"/></Publication><Publication><Pubmed pmid="16262891"/></Publication><Publication><Pubmed pmid="16266401"/></Publication><Publication><Pubmed pmid="16269922"/></Publication><Publication><Pubmed pmid="16269961"/></Publication><Publication><Pubmed pmid="16274376"/></Publication><Publication><Pubmed pmid="16275870"/></Publication><Publication><Pubmed pmid="16280269"/></Publication><Publication><Pubmed pmid="16298372"/></Publication><Publication><Pubmed pmid="16314543"/></Publication><Publication><Pubmed pmid="16322484"/></Publication><Publication><Pubmed pmid="16330686"/></Publication><Publication><Pubmed pmid="16342101"/></Publication><Publication><Pubmed pmid="16359963"/></Publication><Publication><Pubmed pmid="16365204"/></Publication><Publication><Pubmed pmid="16375633"/></Publication><Publication><Pubmed pmid="16380547"/></Publication><Publication><Pubmed pmid="16380592"/></Publication><Publication><Pubmed pmid="16382018"/></Publication><Publication><Pubmed pmid="16397184"/></Publication><Publication><Pubmed pmid="16397734"/></Publication><Publication><Pubmed pmid="16397819"/></Publication><Publication><Pubmed pmid="16401818"/></Publication><Publication><Pubmed pmid="16407573"/></Publication><Publication><Pubmed pmid="16407715"/></Publication><Publication><Pubmed pmid="16421236"/></Publication><Publication><Pubmed pmid="16430904"/></Publication><Publication><Pubmed pmid="16432246"/></Publication><Publication><Pubmed pmid="16434160"/></Publication><Publication><Pubmed pmid="16438729"/></Publication><Publication><Pubmed pmid="16441967"/></Publication><Publication><Pubmed pmid="16442398"/></Publication><Publication><Pubmed pmid="16443791"/></Publication><Publication><Pubmed pmid="16448898"/></Publication><Publication><Pubmed pmid="16461820"/></Publication><Publication><Pubmed pmid="16474174"/></Publication><Publication><Pubmed pmid="16476434"/></Publication><Publication><Pubmed pmid="16476813"/></Publication><Publication><Pubmed pmid="16476848"/></Publication><Publication><Pubmed pmid="16477805"/></Publication><Publication><Pubmed pmid="16484614"/></Publication><Publication><Pubmed pmid="16531791"/></Publication><Publication><Pubmed pmid="16534007"/></Publication><Publication><Pubmed pmid="16534023"/></Publication><Publication><Pubmed pmid="16572107"/></Publication><Publication><Pubmed pmid="16572460"/></Publication><Publication><Pubmed pmid="16585411"/></Publication><Publication><Pubmed pmid="16600945"/></Publication><Publication><Pubmed pmid="16614319"/></Publication><Publication><Pubmed pmid="16636175"/></Publication><Publication><Pubmed pmid="16648850"/></Publication><Publication><Pubmed pmid="16651055"/></Publication><Publication><Pubmed pmid="16675728"/></Publication><Publication><Pubmed pmid="16679093"/></Publication><Publication><Pubmed pmid="16684491"/></Publication><Publication><Pubmed pmid="16697313"/></Publication><Publication><Pubmed pmid="16702347"/></Publication><Publication><Pubmed pmid="16702488"/></Publication><Publication><Pubmed pmid="16715837"/></Publication><Publication><Pubmed pmid="16716207"/></Publication><Publication><Pubmed pmid="16735483"/></Publication><Publication><Pubmed pmid="16754800"/></Publication><Publication><Pubmed pmid="16762981"/></Publication><Publication><Pubmed pmid="16765066"/></Publication><Publication><Pubmed pmid="16783172"/></Publication><Publication><Pubmed pmid="16785337"/></Publication><Publication><Pubmed pmid="16785347"/></Publication><Publication><Pubmed pmid="16791140"/></Publication><Publication><Pubmed pmid="16818830"/></Publication><Publication><Pubmed pmid="16822398"/></Publication><Publication><Pubmed pmid="16837677"/></Publication><Publication><Pubmed pmid="16855181"/></Publication><Publication><Pubmed pmid="16861606"/></Publication><Publication><Pubmed pmid="16869718"/></Publication><Publication><Pubmed pmid="16880459"/></Publication><Publication><Pubmed pmid="16895895"/></Publication><Publication><Pubmed pmid="16913878"/></Publication><Publication><Pubmed pmid="16917147"/></Publication><Publication><Pubmed pmid="16920451"/></Publication><Publication><Pubmed pmid="16928729"/></Publication><Publication><Pubmed pmid="16973806"/></Publication><Publication><Pubmed pmid="16973975"/></Publication><Publication><Pubmed pmid="16988081"/></Publication><Publication><Pubmed pmid="16988089"/></Publication><Publication><Pubmed pmid="17000907"/></Publication><Publication><Pubmed pmid="17000946"/></Publication><Publication><Pubmed pmid="17023723"/></Publication><Publication><Pubmed pmid="17038273"/></Publication><Publication><Pubmed pmid="17056821"/></Publication><Publication><Pubmed pmid="17068983"/></Publication><Publication><Pubmed pmid="17075853"/></Publication><Publication><Pubmed pmid="17085360"/></Publication><Publication><Pubmed pmid="17086034"/></Publication><Publication><Pubmed pmid="17101822"/></Publication><Publication><Pubmed pmid="17101823"/></Publication><Publication><Pubmed pmid="17138952"/></Publication><Publication><Pubmed pmid="17182988"/></Publication><Publication><Pubmed pmid="17190894"/></Publication><Publication><Pubmed pmid="17229895"/></Publication><Publication><Pubmed pmid="17903291"/></Publication><Publication><Pubmed pmid="17903301"/></Publication><Publication><Pubmed pmid="17903302"/></Publication><Publication><Pubmed pmid="17903303"/></Publication><Publication><Pubmed pmid="17903305"/></Publication><Publication><Pubmed pmid="17903306"/></Publication><Publication><Pubmed pmid="17903308"/></Publication><Publication><Pubmed pmid="17903292"/></Publication><Publication><Pubmed pmid="17903294"/></Publication><Publication><Pubmed pmid="17903295"/></Publication><Publication><Pubmed pmid="17903298"/></Publication><Publication><Pubmed pmid="17903299"/></Publication><Publication><Pubmed pmid="17903300"/></Publication><Publication><Journal authors="Abbott RD" title="Commentary on comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study" journal="Stat Med.2006;7:219-222"/></Publication><Publication><Journal authors="Brehm HP, Rush TV" title="Disability analysis of longitudinal health data: Policy implications for social security insurance" journal="Journal of Aging Studies.1988;2:379-399"/></Publication><Publication><Journal authors="Carroll RJ, Spiegelman CH, Lan KKG, Abbott RD" title="On errors-in-variables for binary regression models" journal="Biometrika.1984;71:19-25"/></Publication><Publication><Journal authors="Culleton BF, Wilson PWF" title="Thrombogenic risk factors for cardiovascular disease in dialysis patients" journal="Seminars in Dialysis.1999;12:117-125"/></Publication><Publication><Journal authors="D'Agostino RB" title="Discussion of papers of session 2: incomplete, multivariate, non-linear" journal="Stat Med.1992;11:1955-1963"/></Publication><Publication><Journal authors="D'Agostino RB, Belanger AJ, D'Agostino RBJ" title="A suggestion for using powerful and informative tests of normality" journal="The American Statistician.1990;44:316-321"/></Publication><Publication><Journal authors="Dawber TR" title="Coronary heart disease: morbidity in the Framingham Study and analysis of factors of risk" journal="Bibl Cardiol.1963;13:9-24"/></Publication><Publication><Journal authors="Dawber TR" title="Heart attack--what's the risk" journal="Today's Health.1965;43:62-64"/></Publication><Publication><Journal authors="Dawber TR, Kannel WB" title="Application of epidemiology of coronary heart disease to medical practice" journal="Mod Med.1962;30:85-101"/></Publication><Publication><Journal authors="Dawber TR, Kannel WB, Pearson G, Shurtleff D" title="Assessment of diet in the Framingham Study: methodology and preliminary observations" journal="Health News.1961;38:4-6"/></Publication><Publication><Journal authors="Demets D, Halperin M" title="Estimation of a simple regression coefficient in samples arising from a sub-sampling procedure" journal="Biometrics.1977;33:47-56"/></Publication><Publication><Journal authors="Devereux RB, Diodati JG, Levy D" title="Cardiac hypertrophy: practice implications" journal="Patient Care.1992;88-122"/></Publication><Publication><Journal authors="Garcia MJ, McNamara PM, Gordon T, Kannel WB" title="Cardiovascular complications in diabetics" journal="Adv Metab Disord.1973;Suppl 2:493-499"/></Publication><Publication><Journal authors="Garrison RJ, Sawin CT, Alexander L, Wilson PWF" title="Plasma estradiol in premenopausal women: the Framingham Offspring Study" journal="Journal of Women's Health.1994;3:435-443"/></Publication><Publication><Journal authors="Gordon T, Moore FE, Shurtleff D, Dawber TR" title="Some methodologic problems in the long-term study of cardiovascular disease: Observations on the Framingham Study" journal="J Chronic Dis.1959;10:186-206"/></Publication><Publication><Journal authors="Hahn S, Jang I, O'Donnell CJ" title="Antithrombotic therapy for acute coronary syndromes, Part 2 STE-MI" journal="Journal of Critical Illness.1999;14:42-50"/></Publication><Publication><Journal authors="Haider AW" title="Association of spontaneous intermittent reperfusion during acute myocardial infarction with hemostatic activity and myocardial damage" journal="Clinician.1999;3:15-16"/></Publication><Publication><Journal authors="Hall AP" title="Observations on subjects developing a positive test for rheumatoid factor in a prospective study" journal="Arthritis Rheum.1969;12:301-301"/></Publication><Publication><Journal authors="Kannel WB" title="Cigarette smoking and coronary heart disease" journal="Ann Intern Med.1964;60:1103-1106"/></Publication><Publication><Journal authors="Kannel WB" title="The Framingham Study and chronic disease prevention" journal="Hosp Pract.1970;5:78-94"/></Publication><Publication><Journal authors="Kannel WB" title="Cholesterol: a potent contributor to atherogenesis" journal="Med Counterpoint.1971;3:31-42"/></Publication><Publication><Journal authors="Kannel WB" title="Office evaluation of coronary candidates" journal="Hosp Med.1979;38-50"/></Publication><Publication><Journal authors="Kannel WB" title="Prospects for risk factor modification to reduce risk of reinfarction and premature death" journal="JCR.1981;1:63-71"/></Publication><Publication><Journal authors="Kannel WB" title="The lipid-atherogenesis connection. 12 questions frequently asked by physicians" journal="Consultant.1988;28:25-38"/></Publication><Publication><Journal authors="Kannel WB" title="Prospects for discontinuing antihypertensive pharmacotherapy" journal="Primary Cardiol.1990;16:55-61"/></Publication><Publication><Journal authors="Kannel WB" title="Epidemiology of essential hypertension: the Framingham experience" journal="Proc R Coll Physicians Edinb.1991;21:273-287"/></Publication><Publication><Journal authors="Kannel WB, Castelli WP, McNamara PM" title="Epidemiology of acute myocardial infarction; the Framingham Study" journal="Med Today.1968;2:56-71"/></Publication><Publication><Journal authors="Kannel WB, Castelli WP, McNamara PM, Sorlie PD" title="Some factors affecting morbidity and mortality in hypertension: the Framingham Study" journal="Milbank Mem Fund Q Health Soc.1969;47,Pt2:116-142"/></Publication><Publication><Journal authors="Kannel WB, Dawber TR" title="Contributors to coronary risk implications for prevention and public health: the Framingham Study" journal="Heart Lung.1972;1:797-810"/></Publication><Publication><Journal authors="Kannel WB, Dawber TR, McNamara PM" title="Vascular disease of the brain - epidemiologic aspects: the Framingham Study" journal="Am J Public Health.1965;55:1355-1366"/></Publication><Publication><Journal authors="Kannel WB, Sorlie PD" title="Remissions of angina pectoris" journal="Primary Cardiol.1980;27-36"/></Publication><Publication><Journal authors="Savage DD, Abbott RD, Kannel WB" title="Chronic atrial fibrillation in the general population" journal="Primary Cardiol.1983;49-64"/></Publication><Publication><Journal authors="Savage DD, Brand FN, Kannel WB" title="Does posterior extra-echocardiographic space always mean disease" journal="Primary Cardiol.1987;12-18"/></Publication><Publication><Journal authors="Wilson PWF, Larson MG, Castelli WP" title="Triglycerides, HDL cholesterol and coronary artery disease: a Framingham update on their interrelations" journal="Can J Cardiol.1994;10:5b-9b"/></Publication><Publication><Journal authors="Wolf PA, Belanger AJ, D'Agostino RB" title="Quantifying stroke risk factors and potentials form risk reduction" journal="Cerebrovasc Dis.1993;3(suppl 1):7-14"/></Publication><Publication><Journal authors="Zhang Y, Kreger BE, Dorgan JF, Splansky GL, Cupples LA, Ellison RC" title="Authors' response to 'The Framingham results on alcohol and breast cancer" journal="Am J Epidemiol.2001;149:105-105"/></Publication><Publication><Journal authors="Elias MF, Sullivan LM, Elias PK, Vasan RS, D'Agostino RB, Seshadri S, Au R, Wolf PA, Benjamin EJ" title="Atrial fibrillation is associated with lower cognitive performance in the Framingham Offspring Men" journal="The Journal of Stroke and Cerebrovascular Diseases.2006;214-222"/></Publication><Publication><Journal authors="Brand FN, Wolf PA, Kannel WB" title="Clinical significance lone atrial fibrillation" journal="Practical Cardiology.1987;85-93"/></Publication><Publication><Journal authors="Cornfield J, Gordon T, Smith WW" title="Quantal response curves for experimentally uncontrolled variables" journal="Bull Int Stat Inst.1961;38:97-115"/></Publication><Publication><Journal authors="Farrer LA, Cupples LA, Kukill WA, Volicer L, Wells JM, Kurz A, Green RC, Chui H, Duara,  R, Auerbach S, Larson E, Wolf PA, D'Agostino RB, Ordovas J, Schaefer EJ, Growdon JH, Haines J" title="Risk of Alzheimer disease is associated with parental age among apolipoprotein E 4 heterozygotes" journal="Alzheimer's Research.1997;3:83-91"/></Publication><Publication><Journal authors="Gates GA, Schmid P, Blinne W, Nam B, D'Agostino R" title="High frequency audiometric notches in older people" journal="J Occup Hear Loss.1999;2:1-10"/></Publication><Publication><Journal authors="Kannel WB" title="The epidemiology of coronary heart disease: methodologic considerations. The Framingham Study" journal="Aktuel Probl Angiol.1970;7:25-42"/></Publication><Publication><Journal authors="Kannel WB" title="Coronary heart disease epidemiology: implications for practice. The Framingham Study" journal="Aktuel Probl Angiol.1970;7:82-97"/></Publication><Publication><Journal authors="Kannel WB" title="Obesity and coronary heart disease" journal="Br Med J.1973;1:566-567"/></Publication><Publication><Journal authors="Kannel WB" title="Rehabilitation of the hypertensive" journal="Cardiac Rehabilitation.1973;3:51-54"/></Publication><Publication><Journal authors="Kannel WB" title="Status of coronary heart disease risk factors" journal="J Nutr Ed.1978;10:10-14"/></Publication><Publication><Journal authors="Kannel WB" title="Unrecognized myocardial infarction" journal="CL. 1 Coronary Artery Disease.1985;2:89-98"/></Publication><Publication><Journal authors="Kannel WB" title="Incidence and outlook for cardiac failure: perceptions from the Framingham Study" journal="Journal for Drug Therapy and Research.1988;(Suppl 5):13:266-272"/></Publication><Publication><Journal authors="Kannel WB" title="Preventive medicine: The contribution of pharmaceuticals to better health. Coronary Artery Disease. Proceedings of the 15th IFPMA assembly, London (UK), September 19-21, 1990. International Pharmaceutical Manufacturers Associations" journal="Swiss Pharma.1990;"/></Publication><Publication><Journal authors="Kannel WB" title="Coronary disease and risk factor intervention" journal="Cardiovascular Risk Factors.1990;14-20"/></Publication><Publication><Journal authors="Kannel WB" title="Using a coronary risk profile in office evaluations" journal="The Journal of Myocardial Ischemia.1991;70-78"/></Publication><Publication><Journal authors="Kannel WB" title="Aspects of therapeutics (4):office assessment of coronary candidates" journal="J Drug Dev.1992;5:49-58"/></Publication><Publication><Journal authors="Kannel WB" title="CV risk factor assessment in the elderly" journal="Geriatric Consultant.1992;"/></Publication><Publication><Journal authors="Kannel WB" title="Multivariate cardiovascular risk assessment" journal="J Myocard Ischemia.1993;5(Suppl 1):30-35"/></Publication><Publication><Journal authors="Kannel WB" title="Hypertension in the elderly: epidemiologic appraisal from the Framingham Study" journal="Cardiology in the Elderly.1993;1:359-363"/></Publication><Publication><Journal authors="Kannel WB" title="Blood pressure as a contributor to stroke" journal="Federal Practitioner.1995;Supplement:14-20"/></Publication><Publication><Journal authors="Kannel WB" title="Current status of coronary risk factors" journal="Excepta Medica.1995;21-28"/></Publication><Publication><Journal authors="Kannel WB" title="Defining the risks of hypertension: a focus on minimizing LVH" journal="Clinical Case Study Series.1999;"/></Publication><Publication><Journal authors="Kannel WB, Anderson KM, Evans JC" title="Relevance of blood lipids in the elderly: the Framingham Study" journal="Cardiovascular Risk Factors.1992;2:170-179"/></Publication><Publication><Journal authors="Kannel WB, Brand FN" title="Can a routine lung function test warn of heart trouble" journal="J Resp Dis.1984;18:39-47"/></Publication><Publication><Journal authors="Kannel WB, Dawber TR" title="Hypertension as an ingredient of a cardiovascular risk profile" journal="Br J Hos Med.1974;508-523"/></Publication><Publication><Journal authors="Kannel WB, Dawber TR, Glennon WE, Thorne MC" title="Preliminary report: the determinants and clinical significance of serum cholesterol" journal="Mass J Med Tech.1962;4:11-29"/></Publication><Publication><Journal authors="Kannel WB, Gordon T, Sorlie PD, McNamara PM" title="Physical activity and coronary vulnerability: the Framingham Study" journal="Cardiol Digest.1971;6:28-40"/></Publication><Publication><Journal authors="Kannel WB, Mcgee DL, Castelli WP" title="Latest perspectives on cigarrette smoking and cardiovascular disease: the Framingham Study" journal="J Cardiac Rehabil.1984;4:267-277"/></Publication><Publication><Journal authors="Kannel WB, Thom TJ" title="Implications of the recent decline in cardiovascular mortality" journal="Cardiovasc Med.1979;4:983-997"/></Publication><Publication><Journal authors="Kannel WB, Ward GW" title="Overview of cardiovascular risk factors" journal="Practical Cardiology.1986;63-75"/></Publication><Publication><Journal authors="Kannel WB, Wilson PWF" title="Homocysteine, folate, and vascular disease" journal="J Myocard Ischemia.1996;8:60-63"/></Publication><Publication><Journal authors="Kelly-Hayes M" title="Stroke outcomes measurement: new developments" journal="Journal of Rehabilitation Outcomes Measurement.2000;4:57-63"/></Publication><Publication><Journal authors="Kelly-Hayes M, Beiser A, Scaramucci A, D'Agostino RB, Wolf PA" title="The influence of gender and age on disability following ischemic stroke: The Framingham Study" journal="Journal of Stroke and Cerebrovascular Diseases.2003;12:119-126"/></Publication><Publication><Journal authors="Kelly-Hayes M, Wolf PA, Kase CS, Gresham GE, Kannel WB, D'Agostino RB" title="Time course of functional recovery after stroke: the Framingham Study" journal="J Neuro Rehab.1989;3:65-70"/></Publication><Publication><Journal authors="Lauer MS, Levy D" title="Left ventricular hypertrophy: risk, clinical correlates, and therapeutic implications" journal="Focus on Hypertension.1992;5-10"/></Publication><Publication><Journal authors="Lyu L, Posner BM, Shieh MJ, Lichtenstein AH, Cupples LA, Dwyer J, Wilson PWF, Schaefer EJ" title="Cross-cultural comparisons between Taipei Chinese and Framingham Americans: dietary intakes, blood lipids and apolipoproteins" journal="Asia Pacific J Clin Nutr.1994;3:119-125"/></Publication><Publication><Journal authors="McNamara PM, Hjortland MC, Kannel WB, Gordon T" title="Natural history of menopause: the Framingham Study" journal="J Contin Ed Obstet Gynecol.1978;20:27-35"/></Publication><Publication><Pubmed pmid="19576326"/></Publication><Publication><Pubmed pmid="19549974"/></Publication><Publication><Pubmed pmid="19597492"/></Publication><Publication><Journal authors="Savage DD, Castelli WP, Abbott RD, Garrison RJ, Anderson SJ, Kannel WB, Feinleib M" title="Hypertrophic cardiomyopathy and its markers in the general population: The great masquerader revisited: the Framingham Study" journal="J Cardiovasc Ultrasonography.1983;2(1):41-47"/></Publication><Publication><Journal authors="Thom TJ, Kannel WB" title="Congestive heart failure: epidemiology and cost of illness" journal="Dis Manage Health Outcomes.1997;1:75-83"/></Publication><Publication><Journal authors="Vokonas PS, Kannel WB" title="Hypertension in the elderly" journal="Choices in Cardiology.1991;5:46-48"/></Publication><Publication><Journal authors="Weldon B" title="Weight loss reduces the risk of osteoarthritis of the knee" journal="The NIH Record.1992;XLIV(10):3-3"/></Publication><Publication><Journal authors="Wilson PW" title="Workshop on nonvalvular atrial fibrillation in the elderly: challenges for prevention and care" journal="Am J Geriatric Cardiology.2000;9:73-75"/></Publication><Publication><Journal authors="Anderson KM, Dumphy D, Wilson PWF" title="&quot;Management of data quality in a long-term epidemiologic study: the Framingham Heart Study&quot;" journal="Data Quality Control Theory and Pragmatics. Eds. Liepins GE, Uppuluri VRR. New York: Marcel Dekker, Inc., 1990. 57-68"/></Publication><Publication><Journal authors="Anderson KM, Kannel WB" title="&quot;Obesity and disease&quot;" journal="Obesity. Eds. Bjorntorp P, Brodoff BN. Philadelphia: J.B. Lippincott Company, 1991. 465-473"/></Publication><Publication><Journal title="&quot;Framingham Monograph. Sections 1-33. 1968-1978&quot;" journal="An Epidemiological Investigation of Cardiovascular Disease. Eds. Kannel WB, Gordon T. Washington, DC: DHEW (NIH), 1968. "/></Publication><Publication><Journal authors="Beevers DG, Fairman MJ, Hamilton M, Harpur JE" title="&quot;The influence of anti-hypertensive treatment on cerebrovascular disease&quot;" journal="Stroke. Proceedings of the Ninth Pfizer International Symposium held in Edinburgh from 29-30 June. Eds. Gillingham FJ, Mawdsley C, Williams AE. Churchill Livingstone Edinburgh London and New York, 1976. 288-294"/></Publication><Publication><Journal authors="Beiser A, D'Agostino RB, Seshadri S, Sullivan LM, Wolf PA" title="&quot;Computing Estimates of Incidence, Including Lifetime Alzheimer's Disease in the Framingham Study.  The Practical Incidence Estimators (PIE) Macro.  Tutorials in Biostatistics, Vol 1, D'Agostino RB (Ed.), Whiley, Chichester In Press&quot;" journal="2004. "/></Publication><Publication><Journal authors="Castelli WP" title="&quot;Section A: untoward associations of low serum cholesterol levels. Long-term relationship between serum cholesterol and total mortality in the Framingham Heart Study&quot;" journal="Low Blood Cholesterol: Health Implications. Proceedings of the International Task Force for the Prevention of Coronary Heart Disease and the International Society and Federation of Cardiology. Eds. Lewis B, Paoletti R, Tikkanen MJ. London: Current Medical Literature Ltd., 1993. 2-9"/></Publication><Publication><Journal authors="D'Agostino RB, Belanger AJ, D'Agostino RBJ" title="&quot;Test normality and other goodness-of-fit tests&quot;" journal="NESUG '91: Proceedings of the Fourth Annual Northeast SAS Users Group Conference. Greenwich: 1991. 273-285"/></Publication><Publication><Journal authors="D'Agostino RB, Kannel WB" title="&quot;Epidemiological background and design: the Framingham Study&quot;" journal="Proceedings of the American Statistical Association sesquicentennial invited paper sessions. 1989. 707-718"/></Publication><Publication><Journal authors="Dawber TR, Kagan A, Kannel WB" title="&quot;The Framingham Heart Study. Detection of factors increasing risk of coronary disease&quot;" journal="Bethesda: U.S. Department of Health, Education, and Welfare, 1964. "/></Publication><Publication><Journal authors="Dawber TR, Kannel WB" title="&quot;The early diagnosis of coronary heart disease&quot;" journal="Presymptomatic Detection and Early Diagnosis: A Critical Appraisal. Eds. Sharp CLEH, Keen H. London: Pitman Medical, 1968. 257-281"/></Publication><Publication><Journal authors="Dawber TR, Kannel WB, Friedman GD" title="&quot;Vital capacity, physical activity and coronary heart disease&quot;" journal="Prevention of Ischemic Heart Disease: Principles and Practice. Eds. Raab W. Springfield, IL: Charles C Thomas, 1966. 254-265"/></Publication><Publication><Journal authors="Dawber TR, Kannel WB, Kagan A, Donabedian RK, McNamara PM, Pearson G" title="&quot;Environmental factors in hypertension&quot;" journal="The Epidemiology of Hypertension. Proceedings of an International Symposium sponsored by the Chicago Heart Association and the American Heart Association, Chicago, IL, February 3-7, 1964. Eds. Stamler J, Stamler R, Pullman TN. New York: Grune &amp; Stratton, 1967. 255-288"/></Publication><Publication><Journal authors="Dawber TR, Kannel WB, McNamara PM" title="&quot;The prediction of coronary heart disease&quot;" journal="Transactions of the Association of Life Insurance Medical Directors of America, Seventy-Second Annual Meeting, October 16, 1963, New York City. Eds. Moore SRJ. New York: Recording &amp; Statistical Company, 1964. 47-Vol 4734"/></Publication><Publication><Journal authors="Dawber TR, McNamara PM" title="&quot;Coronary heart disease: identification of susceptible individuals&quot;" journal="Atherosclerotic Vascular Disease. A Hahnemann Symposium. Eds. Brest AN, Moyer JH. New York: Appleton-Century-Crofts, 1967. 130-146"/></Publication><Publication><Journal authors="Dawber TR, Moore FEJ" title="&quot;Longitudinal study of heart disease in Framingham, Massachusetts: an interim report&quot;" journal="Research in Public Health. Papers presented at the 1951 Annual Conference of the Milbank Memorial Health Fund. New York: Milbank Memorial Fund, 1952. 241-247"/></Publication><Publication><Journal authors="Dawber TR, Wolf PA, Colton TL, Nickerson RJ" title="&quot;Risk factors: comparison of the biological data in myocardial and brain infarctions&quot;" journal="Brain and Heart Infarct. Eds. Zulch KJ, Kauffmann W, Hossman KA, Hossman V. Berlin: Heildelberg, Springer-Verlag, 1977. 226-251"/></Publication><Publication><Journal authors="Feinleib M, Garrison RJ" title="&quot;The contribution of family studies to the partitioning of population variation of blood pressure&quot;" journal="Genetic Analysis of Common Diseases: Applications to Predictive Factors in Coronary Disease. New York: Alan R. Liss, Inc., 1979. 653-673"/></Publication><Publication><Journal authors="Feinleib M, Pinsky JL" title="&quot;Nonrandom attrition in the Framingham Heart Study&quot;" journal="Statistical Models for Longitudinal Studies of Health. Eds. Dwyer JH, Feinleib M, Lippert P, Hoffmeister H. New York: Oxford University Press, 1992. 251-276"/></Publication><Publication><Journal authors="Gordon T, Castelli WP, Hjortland MC, Kannel WB" title="&quot;The prediction of coronary heart disease by high-density and other lipoproteins: An historical perspective&quot;" journal="Hyperlipidemia: Diagnosis and Therapy. Eds. Rifkind BM, Levy RI. (Publ): Grune &amp; Stratton, Inc., 1977. 71-78"/></Publication><Publication><Journal authors="Gordon T, Kannel WB" title="&quot;The Framingham, Massachusetts, Study twenty years later&quot;" journal="The Community as an Epidemiologic Laboratory; A Casebook of Community Studies. Eds. Kessler II, Levin ML. Baltimore: Johns Hopkins Press, 1970. 123-146"/></Publication><Publication><Journal authors="Gordon T, Kannel WB" title="&quot;The prospective study of cardiovascular disease&quot;" journal="Trends in Epidemiology; Application to Health Service Research and Training. Eds. Stewart GT. Springfield, IL: Charles C. Thomas, 1972. 189-211"/></Publication><Publication><Journal authors="Higgins MW" title="&quot;The Framingham Heart Study: A review of epidemiological design and data, limitations and prospects&quot;" journal="Genetic Epidemiology of Coronary Heart Diseases: Past, Present and Future. New York: Alan R. Liss, Inc., 1984. 51-64"/></Publication><Publication><Journal authors="Hjortland MC, Feinleib M" title="&quot;Epidemiologic relationships of alcohol intake and coronary heart disease: result from NHLBI programs&quot;" journal="Metabolic Effects of Alcohol. Eds. Avogaro P, Sirtori CR, Tremoli E. North-Holland biomedical press, 1979. 393-403"/></Publication><Publication><Journal authors="Hubert HB, Castelli WP" title="&quot;Obesity as a predictor of coronary heart disease&quot;" journal="Dietary Treatment and Prevention of Obesity. Eds. Frankle RT, Dwyer J, Morangne L, Owen A. London: John Libbey, 1985. 125-135"/></Publication><Publication><Journal authors="Kagan A, Gordon T, Kannel WB, Dawber TR" title="&quot;Blood pressure and its relation to coronary heart disease in the Framingham Study&quot;" journal="Hypertension Volume VII. Drug Action, Epidemiology and Hemodynamics. Proceedings of the Council for High Blood Pressure Research, American Heart Association. New York: American Heart Association, 1959. 53-81"/></Publication><Publication><Journal authors="Kahn HA" title="&quot;A method for analyzing longitudinal observations on individuals in the Framingham Heart Study&quot;" journal="American Statistical Association, Proceedings of the Social Statistics Section, 1961. Eds. Goldfield ED. Washington, DC: American Statistical Association, 1961. "/></Publication><Publication><Journal authors="Kannel WB" title="&quot;An epidemiologic study of cerebrovascular disease&quot;" journal="Cerebral Vascular Diseases Transactions of the Fifth Conference held under the Auspices of The American Neurological Association and The American Heart Association, Princeton, New Jersey, January 5-7, 1966. Eds. Millikan CH, Siekert RG, Whisnant JP. New York: Grune &amp; Stratton, 1966. 53-66"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Habits and heart disease&quot;" journal="Prediction of Life Span. Eds. Palmore E, Jeffers FC. Lexington: D.C. Health, 1971. 61-70"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Medical evaluation for physical exercise programs&quot;" journal="Exercise and the Heart. Eds. Morse RL. Springfield, IL: Charles C. Thomas, 1971. 79-97"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Coronary profile: ethical considerations&quot;" journal="Health Evaluation; An Entry to the Health Care System. Eds. Davies DF, Tchobanoff JB. New York: Intercontinental Medical Book Corp., 1973. 141-150"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;The natural history of coronary heart disease&quot;" journal="International Symposium on Preventive Cardiology. Dublin: The Irish Heart Foundation, 1975. 9-16"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Some considerations for achieving prevention of cardiovascular disease&quot;" journal="International Symposium on Preventive Cardiology. Dublin: The Irish Heart Foundation, 1975. 133-147"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Prevention of cardiovascular disease&quot;" journal="Current Problems in Cardiology. Eds. Harvey WP, de Leon ACJ, Leonard JJ, Marcus FI, O'Rourke RA, Roberts WC. Chicago: Year book medical publishers, inc., 1976. "/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Long-term predictors of cardiovascular disease&quot;" journal="Infarto do miocardio e suas complicacoes. Eds. Caneiro RD, Carvalho MA. Rio de Janeiro: 1976. 13-23"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Diabetes and cardiovascular disease - The Framingham Study: 18-year followup&quot;" journal="Cardiology Digest. 1976. 11-16"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Brain infarction. The Framingham Study&quot;" journal="Proceedings of the Medical Advisory Council, Cardiovascular Group Meeting. Tokyo: 1976. 7-16"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Preclinical ECG precursors of cardiovascular disease&quot;" journal="Primary Cardiology. 1977. 27-31"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Office estimation of coronary vulnerability&quot;" journal="Medical Digest. 1977. 11-15"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;I segni premonitori della morte improvvisa coronarics lo studio di Framingham&quot;" journal="Cardiologia preventiva atti del corso internazionale. Piccin Editore, 1977. 352-374"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Recent findings of the Framingham Study&quot;" journal="Resident and Staff Physician. 1978. 56-71"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Epidemiology and prognosis in hypertension&quot;" journal="Theories and Use of B-blockade in Hypertension and Angina. Eds. Roberts RH. Symposia specialists Inc., 1979. 39-51"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Hypertensive disease in the elderly: a consequence of arteriosclerosis or blood pressure&quot;" journal="Rothenburger Gesprach. Eds. Bergener M, Grobecker H. New York: F.K. Schattauer Verlag, 1984. 31-50"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Sudden death: update from Framingham&quot;" journal="Continuing Education. 1985. 493-505"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Unrecognized myocardial infarction&quot;" journal="Primary Cardiology. 1986. 93-105"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Cigarette smoking and peripheral arterial disease&quot;" journal="Primary Cardiology. 1986. 13-17"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Cancer and cholesterol&quot;" journal="Perspectives in Lipid Disorders. 1986. 9-15"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Epidemiologic insights into atherosclerotic cardiovascular disease from the Framingham Study&quot;" journal="Heart Disease and Rehabilitation. Eds. Pollock ML, Schmidt DH. New York: John Wiley &amp; Sons, 1986. 3-28"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Lipids, nutrition, and cardiovascular disease in the elderly&quot;" journal="Dietary Fat and Requirements in Health and Developement. Ed. Beare-Rogers J. Illinois: American Oil Chemists' Society, 1988. 191-200"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Epidemiological insights into heart failure&quot;" journal="Failing Heart Syndrome. Imperial Chemical Industries PLC, Publishers, 1988. 13-24"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Nutritional considerations in occurrence and prevention of cardiovascular disease in the elderly&quot;" journal="The Potential for Nutritional Modulation of Aging Processes. Eds. Ingram DK, Baker GTI, Shock NW. New York: Food and Nutrition Press., 1988. 17-49"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Impact of risk factors&quot;" journal="Consultant. 1989. 104-124"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Hypertension as a risk factor in atherosclerotic cardiovascular disease&quot;" journal="Current Therapy in Vascular Surgery. Eds. Ernst CB, Stanley JC. Philadelphia: B.C. Decker, Inc., 1990. 374-381"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Prospects for primary prevention of coronary heart disease&quot;" journal="Atherosclerosis and Cardiovascular Disease. Eds. Descovich GC, Gaddi A, Magri GL, Lenzi S. Boston: Kluwer Academic Publishers, 1990. 24-32"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;The Framingham experience&quot;" journal="Coronary Heart Disease Epidemiology:from Aetiology to Public Health. Eds. Marmot M, Elliott P. New York: Oxford University Press, 1992. 67-82"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Epidemiology of cardiovascular disease in the elderly: an assessment of risk factors&quot;" journal="Geriatric Cardiology. Eds. Lowenthal DT, Brest AN. Philadelphia: F.A. Davis, 1992. 9-22"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Epidemiological implications of left ventricular hypertrophy&quot;" journal="Left Ventricular Hypertrophy and its Regression. Eds. Cruickshank J, Messerli FH. London: Science Press, 1992. 1-11"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Atherogenic lipid profiles: office assessment&quot;" journal="Clinical Issues in Hyperlipidaemia. Ed. Kastelein JJP. Netherlands: Reed Healthcare Communications, 1992. "/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Fibrinogen: a major cardiovascular risk factor&quot;" journal="Fibrinogen: A 'New' Cardiovascular Risk Factor. Eds. Ernst E, Koenig W, Lowe GDO, Meade TW. Austria: Blackwell-MZV, 1992. 101-109"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Individual risk factors for cardiovascular disease&quot;" journal="Multiple Risk Factors in Cardiovascular Disease. Eds. Gotto AM, Lenfant C, Paoletti R, Soma M. Dordrecht: Kluwer Academic, 1992. 1-12"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Epidemiology of hypertension with concomitant metabolic disorders&quot;" journal="Metabolic Aspects of Hypertension. Ed. Kaplan NM. London: Science Press Ltd, 1994. 1.1-1.13"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Coronary risk factors: an overview&quot;" journal="Cardiovascular Medicine. Eds. Willerson J, Cohn J. New York: Churchill Livingstone, Inc., 1995. 1809-1828"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Natural history of cardiovascular risk&quot;" journal="Atlas of Heart Diseases. Hypertension: Mechanisms and Therapy. Eds. Braunwald E, Hollenberg N. Philadelphia: Current Medicine, 1995. "/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Epidemiologic relationship of disease among the different vascular territories&quot;" journal="Atherosclerosis and Coronary Artery Disease. Eds. Fuster V, Ross R, Topol EJ. Philadelphia: Lippincott-Raven, 1996. 1591-1599"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Prevalence, incidence, and mortality of coronary heart disease&quot;" journal="Atherosclerosis and Coronary Artery Disease. Eds. Valentin Fuster, Russell Ross, Eric J.Topol. Philadelphia: Lippincott - Raven, 1996. 13-21"/></Publication><Publication><Journal authors="Kannel WB, Abbott RD" title="&quot;Incidence and prognosis of unrecognized myocardial infarction: based on 26-years follow-up in the Framingham Study&quot;" journal="Silent Myocardial Ischemia. Eds. Rutishauser W, Roskamm H. New York: Springer-Verlag, 1984. 131-137"/></Publication><Publication><Journal authors="Kannel WB, Abbott RD" title="&quot;Incidence and prognosis of myocardial infarction in women: the Framingham Study&quot;" journal="Coronary Heart Disease in Women. Proceedings of an NIH Workshop. Eds. Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA. New York: Haymarket Doyma, Inc., 1987. 208-214"/></Publication><Publication><Journal authors="Kannel WB, Banas JS, Schiffman J" title="&quot;The natural history of coronary diseases: Implications for prophylactic surgical revascularization of the myocardium&quot;" journal="The Paul D. White Symposium on Cardiovascular Disease. Ed. Russek HI. Baltimore: The William and Wilkins Co., 1973. 190-205"/></Publication><Publication><Journal authors="Kannel WB, Barry PE, Dawber TR" title="&quot;Immediate mortality in coronary heart disease. The Framingham Study&quot;" journal="Proceedings of the IV World Congress of Cardiology held in Mexico City, October 7-13, 1962. Coronary Insufficiency; Myocardial Infarction. Mexico: International Society of Cardiology, 1963. 176-188"/></Publication><Publication><Journal authors="Kannel WB, Brand FN" title="&quot;Cardiovascular risk factors in the elderly woman&quot;" journal="Older women: Issues and Prospects. Ed. Markson EW. Lexington: D.C. Health and Co., 1983. 315-327"/></Publication><Publication><Journal authors="Kannel WB, Brand FN" title="&quot;Cardiovascular risk factors in the elderly&quot;" journal="Principles of Geriatric Medicine. Eds. Anders R, Bierman EL, Hazzard WR. New York: McGraw-Hill Book Co., 1985. 104-119"/></Publication><Publication><Journal authors="Kannel WB, Castelli WP, Verter JI, McNamara PM" title="&quot;Relative importance of factors of risk in the pathogenesis of coronary heart disease: the Framingham Study&quot;" journal="A Medical-Surgical Symposium Sponsored by the American College of Cardiology and St. Barnabas Hospital, New York City, December 13-15, 1968. Eds. Russek HI, Zohman BL. Philadelphia: Lippincott, 1971. 97-114"/></Publication><Publication><Journal authors="Kannel WB, Cobb JC" title="&quot;Framingham Study: Risk factors in the age cohort aged 65 and older&quot;" journal="Prevention of Coronary Heart Disease in the Elderly. Eds. Lewis B, Mancini M, Farinaro E. London: Current Medical Literature, 1990. 3-17"/></Publication><Publication><Journal authors="Kannel WB, Cupples LA" title="&quot;Silent myocardial infarction. Incidence, prevalence, and prognostic significance&quot;" journal="Silent Myocardial Ischemia and Angina. Ed. Singh BN. New York: Pergamon Press, 1988. 174-182"/></Publication><Publication><Journal authors="Kannel WB, Cupples LA" title="&quot;Cardiovascular and noncardiovascular consequences of obesity&quot;" journal="Perspectives in Behavioral Medicine. Eating, Sleeping, and Sex. Eds. Stunkard AJ, Baum A. New Jersey: Lawrence Erlbaum Associates, Publishers, 1989. 109-129"/></Publication><Publication><Journal authors="Kannel WB, D'Agostino RB" title="&quot;Risk reduction after quitting smoking&quot;" journal="Quality of Life and Cardiovascular Care. 1989. 84-85"/></Publication><Publication><Journal authors="Kannel WB, Dannenberg AL" title="&quot;Prevalence and natural history of electrocardiographic left ventricular hypertrophy&quot;" journal="The Heart and Hypertension. Ed. Messerli FH. New York: Yorke Medical Books, 1987. 53-61"/></Publication><Publication><Journal authors="Kannel WB, Dawber TR" title="&quot;The prudent management of coronary-prone subject; coping with risk factors&quot;" journal="Cardiovascular Therapy: the Art and the Science. Eds. Russek HI, Zohman BL. Baltimore: Williams and Wilkins Co., 1971. 225-236"/></Publication><Publication><Journal authors="Kannel WB, Dawber TR" title="&quot;Hypertensive cardiovascular disease: the Framingham Study&quot;" journal="Hypertension: Mechanisms and Management. Eds. Onesti G, Kim KE, Moyer JH. New York: Grune &amp; Stratton, 1973. 93-110"/></Publication><Publication><Journal authors="Kannel WB, Dawber TR, Gordon T" title="&quot;Controllable major contributors to coronary risk: the Framingham Study&quot;" journal="The Paul D. White Symposium on Cardiovascular Disease. Baltimore: The Williams and Wilkins Co., 1973. 120-132"/></Publication><Publication><Journal authors="Kannel WB, Gordon T" title="&quot;Assessment of coronary vulnerability--the Framingham Study&quot;" journal="Early Phases of Coronary Heart Disease. Skandia International Symposia, September 19-21, 1972. Eds. Unknown. Stockholm: Nordiska Bokhandeins Forlag, 1973. 123-143"/></Publication><Publication><Journal authors="Kannel WB, Gordon T" title="&quot;Obesity and cardiovascular disease. The Framingham Study&quot;" journal="Obesity Symposium. Proceedings of a Servier Research Institute symposium held on December 1973. Eds. Burland WL, Samuel PD, Yudkin J. Edinburgh: Churchill Livingstone, 1974. 24-51"/></Publication><Publication><Journal authors="Kannel WB, Gordon T" title="&quot;Some determinants of obesity and its impact as a cardiovascular risk factor&quot;" journal="Recent Advances in Obesity Research. London: Newman publishing, Ltd., 1975. 14-27"/></Publication><Publication><Journal authors="Kannel WB, Gordon T" title="&quot;Physiological and medical concomitants of obesity: the Framingham Study&quot;" journal="Obesity in America. Eds. Bray GA. Bethesda: U.S. Department of Health, Education, and Welfare, Public Health Service, 1979. 125-163"/></Publication><Publication><Journal authors="Kannel WB, Mcgee DL" title="&quot;Modifiable risk factors for sudden coronary death&quot;" journal="Sudden Cardiac Death. New York: Grune &amp; Stratton, Inc., 1985. 267-284"/></Publication><Publication><Journal authors="Kannel WB, Mcgee DL" title="&quot;Evaluation of cardiovascular risk&quot;" journal="Anesthesia for Geriatric Patient. Eds. Stephen CR, Assaf RCE. Butterworth Publishers, 1986. 27-53"/></Publication><Publication><Journal authors="Kannel WB, Pearson G, McNamara PM" title="&quot;Obesity as a force of morbidity&quot;" journal="Adolescent Nutrition and Growth. Ed. Heald FP. New York: Appleton-Century-Crofts, 1969. 51-71"/></Publication><Publication><Journal authors="Myers RH, O'Donnell C" title="&quot;Genetics&quot;" journal="50 years of discovery: Medical milestones from the National Heart, Lung, and Blood Institute's Framingham Heart Study. Ed. Levy D. Hackensack, NJ: Center for Bio-Medical Communication, Inc ,, 1999. 549-550"/></Publication><Publication><Journal authors="O'Donnell CJ, Glynn RJ, Field TS, Averback R, Satterfield S, Friesenger GC, Taylor JO, Hennekens CH" title="&quot;Myocardial Infarction&quot;" journal="50 years of discovery: Medical milestones from the National Heart, Lung, and Blood Institute's Framingham Heart Study. Ed. Levy D. Hackensack, NJ: Center for Bio-Medical Communication, Inc, 1999. 338-339"/></Publication><Publication><Journal title="&quot;A Textbook of Medicine&quot;" journal="Eds. Cecil RL, Loeb RF. Philadelphia: W.B. Saunders Company, 1955. "/></Publication><Publication><Journal title="&quot;Framingham Monograph&quot;" journal="Washington DC: DHEW (NIH), 1968. "/></Publication><Publication><Journal authors="Abbott RD, Mcgee DL" title="&quot;The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 37: The Probability of Developing Certain Cardiovascular Diseases in Eight Years at Specified Values of Some Characteristics&quot;" journal="Bethesda, MD: National Heart, Lung, and Blood Institute, 1987. "/></Publication><Publication><Journal authors="Belanger AJ, Cupples LA, D'Agostino RB" title="&quot;The Framingham Study: The Epidemiological Investigation of Cardiovascular Disease, Section 36. Means at Each Examination and Inter-examination Consistency of Specified Characteristics. Framingham Heart Study: 30-year Follow-up&quot;" journal="Bethesda, MD: National Heart, Lung, and Blood Institute, 1988. "/></Publication><Publication><Journal authors="Cupples LA, D'Agostino RB, Kiely D" title="&quot;The Framingham Study. An Epidemiological Investigation of Cardiovascular Disease, Section 34. Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements Framingham Heart Study, 30 Year&quot;" journal="Bethesda, MD: National Heart, Lung, and Blood Institute, 1987. "/></Publication><Publication><Journal authors="Cupples LA, D'Agostino RB, Kiely D" title="&quot;The Framingham Heart Study, Section 35. An Epidemiological Investigation of Cardiovascular Disease. Survival Following Cardiovascular Events: 30 Year Follow-up&quot;" journal="Bethesda, MD: National Heart, Lung and Blood Institute, 1988. "/></Publication><Publication><Journal authors="Cupples LA, Ramaswamy R, Christiansen JC, Belanger AJ, D'Agostino RB" title="&quot;The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 38: The Relationship Between Sporadically Measured Variables and the Risk of Cardiovascular Disease and Death: The Framingham Heart Study, 30-34 Year Follow- up&quot;" journal="Bethesda, MD: National Heart, Lung, and Blood Institute, 1988. "/></Publication><Publication><Journal authors="Dawber TR" title="&quot;Risk factors for arterosclerotic disease&quot;" journal="The Upjohn Co., 1975. "/></Publication><Publication><Journal authors="Dawber TR" title="&quot;The Framingham Study. The Epidemiology of Atherosclerotic Disease&quot;" journal="Cambridge, MA and London, England 1980: A Commonwealth Fund Book /Harvard University Press, 1980. 1-257"/></Publication><Publication><Journal authors="Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB" title="&quot;22 Years of Prospective Study of the Preclinical Phase of Alzheimer's Disease: The Framingham Cohort.  Research and Practice in Alzheimer's Disease, Vol 5&quot;" journal="Eds. Vellas, Feldman, Grundman, Fitten, Biacobini, Winblad. Paris, New York: Serdi Publisher, Springer, 2001. 50-56"/></Publication><Publication><Journal authors="Herring SW" title="&quot;Framingham. An American Town&quot;" journal="The Framingham Historical Society and The Framingham Tercentennial Commission, 2000. 1-409"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Habits and Coronary Heart Disease; The Framingham Heart Study&quot;" journal="Washington, DC, US Govt Print Off: US Dept of Health, Education, and Welfare, Public Health Service Publ. No. 1515, 1966. 1-13"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;The Natural History of Myocardial Infarction: The Framingham Study&quot;" journal="Leiden, The Netherlands: Leiden University Press, 1973. 1-33"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Part 1 CME medicine. Risk factors in coronary disease-disease update&quot;" journal="Wiley Medical, 1979. 1-5"/></Publication><Publication><Journal authors="Kannel WB" title="&quot;Part 2 CME Medicine. Risk factors in coronary disease-disease update&quot;" journal="Wiley Medical, 1979. 1-6"/></Publication><Publication><Journal authors="Kannel WB, Troy BL, McNamara PM" title="&quot;Epidemiology of Stroke&quot;" journal="Washington, DC, US Govt. Printing Office: US Dept of Health, Education, and Welfare, Public Health Service, 1967. 1-8"/></Publication><Publication><Journal authors="Levy D" title="&quot;50 years of discover: Medical milestones from the National Heart, Lung, and Blood Institute's Framingham Heart Study&quot;" journal="Hackensack, NJ: Center for Bio-Medicial Communication, 1999. 583"/></Publication><Publication><Journal authors="Au R, Beiser A, Auerbach S, Wolf P" title="&quot;MCI-More Than Just Memory:  Findings From The Framingham Study&quot;" journal="Thirty-Second Annual Meeting, Baltimore, Maryland. 2004. 43"/></Publication><Publication><Journal authors="Cicchinelli AL" title="&quot;The composite of two Gaussian distributions as a model for blood pressure in man&quot;" journal="1962. 127-127"/></Publication><Publication><Journal authors="Gerende LJ" title="&quot;Some methodological problems in the study of the natural history of blood pressure: an examination of the Framingham Study data&quot;" journal="1962. 201-201"/></Publication><Publication><Journal authors="Kannel W, Levy D" title="&quot;Commentary: Medical aspects of the Framingham Community Health and Tuberculosis Demonstration&quot;" journal="International Journal of Epidemiology. 2005;34:1187-1188"/></Publication><Publication><Journal authors="O'Donnell CJ" title="&quot;Cardiovascular genomics: recent progress, current challenges, future promise&quot;" journal="Genome Biology. 2000;1:reports409.1&#226;??reports409.3"/></Publication><Publication><Pubmed pmid="17903293"/></Publication><Publication><Pubmed pmid="18060926"/></Publication><Publication><Pubmed pmid="17698726"/></Publication><Publication><Pubmed pmid="17389308"/></Publication><Publication><Pubmed pmid="17944986"/></Publication><Publication><Pubmed pmid="17586736"/></Publication><Publication><Pubmed pmid="17709633"/></Publication><Publication><Pubmed pmid="17536046"/></Publication><Publication><Pubmed pmid="17531588"/></Publication><Publication><Pubmed pmid="17908709"/></Publication><Publication><Pubmed pmid="17242302"/></Publication><Publication><Pubmed pmid="17903307"/></Publication><Publication><Pubmed pmid="12637344"/></Publication><Publication><Pubmed pmid="10861898"/></Publication><Publication><Pubmed pmid="16197570"/></Publication><Publication><Pubmed pmid="18090651"/></Publication><Publication><Pubmed pmid="18180395"/></Publication><Publication><Pubmed pmid="18541825"/></Publication><Publication><Pubmed pmid="18574092"/></Publication><Publication><Pubmed pmid="18030310"/></Publication><Publication><Journal authors="Shurtleff D" title="Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18-year follow-up.  Section 30" journal="The Framingham Study: an epidemiological investigation of cardiovascular disease.  Eds. Kannel WB, Fordon T.  Washington, D.C.:  Department of Health, Education, and Welfare, 1973. (DHEW publication no. (NIH) 74-599).  2002"/></Publication><Publication><Pubmed pmid="16728214"/></Publication><Publication><Pubmed pmid="16953256"/></Publication><Publication><Pubmed pmid="17904078"/></Publication><Publication><Pubmed pmid="17903304"/></Publication><Publication><Pubmed pmid="17901394"/></Publication><Publication><Pubmed pmid="17312290"/></Publication><Publication><Pubmed pmid="16424443"/></Publication><Publication><Pubmed pmid="19249635"/></Publication><Publication><Pubmed pmid="19141561"/></Publication><Publication><Pubmed pmid="19188521"/></Publication><Publication><Pubmed pmid="18583555"/></Publication><Publication><Pubmed pmid="19111760"/></Publication><Publication><Journal authors="Benjamin EJ, Wolf PA, Kannel WB" title="The Epidemiology of Atrial Fibrillation" journal="In Atrial Fibrillation: Mechanisms and Management. Raven Press, Ltd., 1997. 1-22"/></Publication><Publication><Journal authors="Wang TJ, Benjamin EJ" title="The Epidemiology of Atrial Fibrillation" journal="Atrial Fibrillation. New York: Marcel Dekker, 2004. 1-26"/></Publication><Publication><Journal authors="Wilson PW, Benjamin EJ, Manolio TA" title="Workshop on nonvalvular atrial fibrillation in the elderly: Challenges for prevention and care" journal="Am J Geriatric Cardiol.2005;9:73-75"/></Publication><Publication><Pubmed pmid="20044523"/></Publication><Publication><Pubmed pmid="20007524"/></Publication><Publication><Pubmed pmid="19812462"/></Publication><Publication><Pubmed pmid="17224472"/></Publication><Publication><Pubmed pmid="19369658"/></Publication><Publication><Pubmed pmid="20009056"/></Publication><Publication><Pubmed pmid="18852353"/></Publication><Publication><Pubmed pmid="19211484"/></Publication><Publication><Pubmed pmid="19644064"/></Publication><Publication><Pubmed pmid="19128858"/></Publication><Publication><Pubmed pmid="18984437"/></Publication><Publication><Pubmed pmid="19265054"/></Publication><Publication><Pubmed pmid="17903297"/></Publication><Publication><Pubmed pmid="18474741"/></Publication><Publication><Pubmed pmid="17430232"/></Publication><Publication><Pubmed pmid="18031707"/></Publication><Publication><Pubmed pmid="18663163"/></Publication><Publication><Pubmed pmid="19864653"/></Publication><Publication><Pubmed pmid="11136963"/></Publication><Publication><Pubmed pmid="11747853"/></Publication><Publication><Pubmed pmid="12975393"/></Publication><Publication><Pubmed pmid="14630731"/></Publication><Publication><Pubmed pmid="17372038"/></Publication><Publication><Journal authors="Savage DD, Brand FN, Kannel WB" title="Does posterior extra-echocardiographic space always mean disease" journal="Primary Cardiol.1987;12-18"/></Publication><Publication><Journal authors="Devereaux RB, Diodati, JG, Levy, D" title="Cardiac Hypertrophy: practice implications" journal="Patient Care.1992;88-122"/></Publication><Publication><Journal authors="Lauer MS, Levy D" title="Left ventricular hypertrophy: risk, clinical correlates, and therapeutic implications" journal="Focus on Hypertension.1992;5-10"/></Publication><Publication><Journal authors="Lauer MS, Larson MG, Levy D" title="Gender-specific reference M-mode values in adults: population-derived values with consideration of the impact of height" journal="J.Am.Coll.Cardiol.1996;26:1039-1046"/></Publication><Publication><Journal authors="Levy D, Lauer MS" title="&quot;Left ventricular hypertrophy: echocardiographic assessment and prognostic implications&quot;" journal="Textbook of Echocardiography and Doppler in Adults and Children. Eds. Sutton MGSJ, Oldershaw PJ, Kotler MN. Cambridge,MA: Blackwell Science, 1996. 342-352"/></Publication><Publication><Journal authors="Norman JE, Levy D" title="Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach" journal="J.Am.Coll.Cardiol.1996;26:1022-1029"/></Publication><Publication><Journal authors="Vasan RS, Levy D" title="&quot;The progression from hypertension to heart failure:an overview of pathogenetic mechanisms&quot;" journal="Controversies in the Management of Heart Failure. Ed. Coats A. New York: Churchill Livingstone, 1997. 1-10"/></Publication><Publication><Pubmed pmid="17228994"/></Publication><Publication><Pubmed pmid="17079199"/></Publication><Publication><Pubmed pmid="17137849"/></Publication><Publication><Pubmed pmid="17903296"/></Publication><Publication><Pubmed pmid="17923597"/></Publication><Publication><Pubmed pmid="17542685"/></Publication><Publication><Pubmed pmid="17674073"/></Publication><Publication><Pubmed pmid="17980690"/></Publication><Publication><Pubmed pmid="17404185"/></Publication><Publication><Pubmed pmid="2122927"/></Publication><Publication><Pubmed pmid="7838189"/></Publication><Publication><Pubmed pmid="17296870"/></Publication><Publication><Pubmed pmid="17895253"/></Publication><Publication><Journal authors="Shurtleff D" title="Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18-year follow-up" journal="Kannel WB, Gordon T, editors. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health: 1974:1-23. DHEW Publication (NIH) No. 74-599"/></Publication><Publication><Pubmed pmid="17533184"/></Publication><Publication><Pubmed pmid="17339551"/></Publication><Publication><Pubmed pmid="11300121"/></Publication><Publication><Pubmed pmid="11208620"/></Publication><Publication><Pubmed pmid="16944668"/></Publication><Publication><Pubmed pmid="17785619"/></Publication><Publication><Pubmed pmid="18614743"/></Publication><Publication><Pubmed pmid="17921402"/></Publication><Publication><Pubmed pmid="17709452"/></Publication><Publication><Pubmed pmid="17684225"/></Publication><Publication><Pubmed pmid="17646581"/></Publication><Publication><Pubmed pmid="17259479"/></Publication><Publication><Pubmed pmid="12042454"/></Publication><Publication><Pubmed pmid="8642467"/></Publication><Publication><Pubmed pmid="12584367"/></Publication><Publication><Pubmed pmid="15321944"/></Publication><Publication><Pubmed pmid="11440984"/></Publication><Publication><Pubmed pmid="16148285"/></Publication><Publication><Pubmed pmid="18458169"/></Publication><Publication><Pubmed pmid="17372189"/></Publication><Publication><Pubmed pmid="10770144"/></Publication><Publication><Pubmed pmid="18321946"/></Publication><Publication><Pubmed pmid="19289634"/></Publication><Publication><Pubmed pmid="19136488"/></Publication><Publication><Pubmed pmid="18212276"/></Publication><Publication><Pubmed pmid="19293261"/></Publication><Publication><Pubmed pmid="19223518"/></Publication><Publication><Pubmed pmid="18834895"/></Publication><Publication><Pubmed pmid="10683055"/></Publication><Publication><Pubmed pmid="15562020"/></Publication><Publication><Pubmed pmid="10523012"/></Publication><Publication><Pubmed pmid="19139753"/></Publication></Publications></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="VASAN@BU.EDU" aid="2" auth="eRA" login="VASAN@BU.EDU" fname="Vasan" mname="S." lname="Ramachandran" email="vasan@bu.edu"><Role>PI</Role><Organization>BOSTON UNIVERSITY MEDICAL CAMPUS</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011073112" aid="1" auth="cit" login="paltood" fname="Dina" mname="N" lname="Paltoo" email="dp249p@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="false" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><DUC><File uri="dbgapssws.cgi?blob_id=6379&amp;file=get&amp;page=file" filename="Framingham New DUC 7-8-10.docx" md5="f804ada2fd72a59f0a2747265cb544b6" size="79266" modDate="2010-09-02T15:20:53-05:00" content-type="application/vnd.openxmlformats-officedocument.word"/></DUC><DUC_SupplementaryDocuments><File uri="dbgapssws.cgi?blob_id=6514&amp;file=get&amp;page=file" filename="Non-contract and Contract Phenotypic Dataset Acknowledgement 11-24-2010.doc" md5="4a352edeb3e0e95f975522a7e20532aa" size="157184" modDate="2010-11-29T15:15:53-05:00" content-type="application/msword"/></DUC_SupplementaryDocuments><ConsentGroup uid="365" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by the Framingham Heart Study Participants allows use of these data by investigators employed by non-profit and for-profit organizations. These data may be used by private companies in the development of diagnostics and therapeutics under the current consent.
</Use-Restriction></ConsentGroup><ConsentGroup uid="366" CGType="cg_class_other" title="Non Profit Use Only" name="NPU" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes"><Use-Restriction>The informed consent document signed by Framingham Heart Study participants allows use of these genetic data by investigators employed by non-profit organizations only. Direct use of these data by private companies to develop diagnostics or therapeutics is NOT allowed under the current consent.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>